NZ759805B2 - Biosensors For Biological Or Chemical Analysis And Methods Of Manufacturing The Same - Google Patents
Biosensors For Biological Or Chemical Analysis And Methods Of Manufacturing The Same Download PDFInfo
- Publication number
- NZ759805B2 NZ759805B2 NZ759805A NZ75980514A NZ759805B2 NZ 759805 B2 NZ759805 B2 NZ 759805B2 NZ 759805 A NZ759805 A NZ 759805A NZ 75980514 A NZ75980514 A NZ 75980514A NZ 759805 B2 NZ759805 B2 NZ 759805B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- light
- device base
- shield layer
- base
- light guides
- Prior art date
Links
- 239000000126 substance Substances 0.000 title claims abstract description 65
- 238000000034 method Methods 0.000 title claims description 48
- 238000004519 manufacturing process Methods 0.000 title claims description 19
- 238000004458 analytical method Methods 0.000 title description 13
- 239000000463 material Substances 0.000 claims abstract description 109
- 230000005284 excitation Effects 0.000 claims abstract description 58
- 238000006243 chemical reaction Methods 0.000 claims description 185
- 238000001514 detection method Methods 0.000 claims description 77
- 238000002161 passivation Methods 0.000 claims description 65
- 229910052751 metal Inorganic materials 0.000 claims description 19
- 230000003287 optical effect Effects 0.000 claims description 17
- 230000002093 peripheral effect Effects 0.000 claims description 14
- PBCFLUZVCVVTBY-UHFFFAOYSA-N tantalum pentoxide Inorganic materials O=[Ta](=O)O[Ta](=O)=O PBCFLUZVCVVTBY-UHFFFAOYSA-N 0.000 claims description 12
- BPUBBGLMJRNUCC-UHFFFAOYSA-N oxygen(2-);tantalum(5+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ta+5].[Ta+5] BPUBBGLMJRNUCC-UHFFFAOYSA-N 0.000 claims description 11
- 238000000151 deposition Methods 0.000 claims description 7
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000004065 semiconductor Substances 0.000 claims description 4
- 229910052710 silicon Inorganic materials 0.000 claims description 4
- 239000010703 silicon Substances 0.000 claims description 4
- 238000007740 vapor deposition Methods 0.000 claims description 3
- 238000000623 plasma-assisted chemical vapour deposition Methods 0.000 claims 2
- 239000010410 layer Substances 0.000 description 228
- 239000012530 fluid Substances 0.000 description 72
- 238000004166 bioassay Methods 0.000 description 47
- 125000003729 nucleotide group Chemical group 0.000 description 36
- 239000002773 nucleotide Substances 0.000 description 34
- 239000000758 substrate Substances 0.000 description 24
- 108020004707 nucleic acids Proteins 0.000 description 23
- 102000039446 nucleic acids Human genes 0.000 description 23
- 150000007523 nucleic acids Chemical class 0.000 description 23
- 238000003860 storage Methods 0.000 description 20
- 239000003153 chemical reaction reagent Substances 0.000 description 17
- 230000003321 amplification Effects 0.000 description 16
- 238000004891 communication Methods 0.000 description 16
- 238000003199 nucleic acid amplification method Methods 0.000 description 16
- 150000002500 ions Chemical class 0.000 description 14
- 239000007787 solid Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- 230000015654 memory Effects 0.000 description 12
- 239000003989 dielectric material Substances 0.000 description 11
- 238000012163 sequencing technique Methods 0.000 description 11
- 108020004414 DNA Proteins 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 108091034117 Oligonucleotide Proteins 0.000 description 10
- 238000005286 illumination Methods 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 239000002699 waste material Substances 0.000 description 9
- 230000008859 change Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 230000002441 reversible effect Effects 0.000 description 8
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 7
- 238000003556 assay Methods 0.000 description 6
- 239000011324 bead Substances 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 238000003384 imaging method Methods 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 239000012491 analyte Substances 0.000 description 5
- 238000000429 assembly Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 229910052814 silicon oxide Inorganic materials 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 238000010348 incorporation Methods 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 4
- 229910052721 tungsten Inorganic materials 0.000 description 4
- 239000010937 tungsten Substances 0.000 description 4
- 108091093088 Amplicon Proteins 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000000712 assembly Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000005530 etching Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000003100 immobilizing effect Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000001902 propagating effect Effects 0.000 description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 229910052581 Si3N4 Inorganic materials 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000029918 bioluminescence Effects 0.000 description 2
- 238000005415 bioluminescence Methods 0.000 description 2
- 238000001311 chemical methods and process Methods 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- 238000002493 microarray Methods 0.000 description 2
- -1 other biomolecules Substances 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 2
- 229910052715 tantalum Inorganic materials 0.000 description 2
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 239000012780 transparent material Substances 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- PHIYHIOQVWTXII-UHFFFAOYSA-N 3-amino-1-phenylpropan-1-ol Chemical compound NCCC(O)C1=CC=CC=C1 PHIYHIOQVWTXII-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 235000012571 Ficus glomerata Nutrition 0.000 description 1
- 240000000365 Ficus racemosa Species 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 101100400378 Mus musculus Marveld2 gene Proteins 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 229910020776 SixNy Inorganic materials 0.000 description 1
- 235000015125 Sterculia urens Nutrition 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 239000002318 adhesion promoter Substances 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000003012 bilayer membrane Substances 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 208000018459 dissociative disease Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000007837 multiplex assay Methods 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000012175 pyrosequencing Methods 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000002165 resonance energy transfer Methods 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000005464 sample preparation method Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000005382 thermal cycling Methods 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 125000002264 triphosphate group Chemical group [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502707—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the manufacture of the container or its components
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502715—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
- C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
- G01N2021/6441—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks with two or more labels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N2021/6482—Sample cells, cuvettes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/01—Arrangements or apparatus for facilitating the optical investigation
- G01N21/03—Cuvette constructions
- G01N21/05—Flow-through cuvettes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6452—Individual samples arranged in a regular 2D-array, e.g. multiwell plates
- G01N21/6454—Individual samples arranged in a regular 2D-array, e.g. multiwell plates using an integrated detector array
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/06—Illumination; Optics
- G01N2201/061—Sources
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/06—Illumination; Optics
- G01N2201/064—Stray light conditioning
- G01N2201/0642—Light traps; baffles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/403—Cells and electrode assemblies
- G01N27/414—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS
- G01N27/4145—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS specially adapted for biomolecules, e.g. gate electrode with immobilised receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L27/00—Devices consisting of a plurality of semiconductor or other solid-state components formed in or on a common substrate
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L27/00—Devices consisting of a plurality of semiconductor or other solid-state components formed in or on a common substrate
- H01L27/02—Devices consisting of a plurality of semiconductor or other solid-state components formed in or on a common substrate including semiconductor components specially adapted for rectifying, oscillating, amplifying or switching and having potential barriers; including integrated passive circuit elements having potential barriers
- H01L27/04—Devices consisting of a plurality of semiconductor or other solid-state components formed in or on a common substrate including semiconductor components specially adapted for rectifying, oscillating, amplifying or switching and having potential barriers; including integrated passive circuit elements having potential barriers the substrate being a semiconductor body
- H01L27/08—Devices consisting of a plurality of semiconductor or other solid-state components formed in or on a common substrate including semiconductor components specially adapted for rectifying, oscillating, amplifying or switching and having potential barriers; including integrated passive circuit elements having potential barriers the substrate being a semiconductor body including only semiconductor components of a single kind
- H01L27/085—Devices consisting of a plurality of semiconductor or other solid-state components formed in or on a common substrate including semiconductor components specially adapted for rectifying, oscillating, amplifying or switching and having potential barriers; including integrated passive circuit elements having potential barriers the substrate being a semiconductor body including only semiconductor components of a single kind including field-effect components only
- H01L27/088—Devices consisting of a plurality of semiconductor or other solid-state components formed in or on a common substrate including semiconductor components specially adapted for rectifying, oscillating, amplifying or switching and having potential barriers; including integrated passive circuit elements having potential barriers the substrate being a semiconductor body including only semiconductor components of a single kind including field-effect components only the components being field-effect transistors with insulated gate
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L27/00—Devices consisting of a plurality of semiconductor or other solid-state components formed in or on a common substrate
- H01L27/14—Devices consisting of a plurality of semiconductor or other solid-state components formed in or on a common substrate including semiconductor components sensitive to infrared radiation, light, electromagnetic radiation of shorter wavelength or corpuscular radiation and specially adapted either for the conversion of the energy of such radiation into electrical energy or for the control of electrical energy by such radiation
- H01L27/144—Devices controlled by radiation
- H01L27/146—Imager structures
- H01L27/14601—Structural or functional details thereof
- H01L27/1462—Coatings
- H01L27/14623—Optical shielding
Abstract
Biosensor including a device base having a sensor array of light sensors and a guide array of light guides. The light guides have input regions that are configured to receive excitation light and light emissions generated by biological or chemical substances. The light guides extend into the device base toward corresponding light sensors and have a filter material. The device base includes device circuitry electrically coupled to the light sensors and configured to transmit data signals. The biosensor also includes a shield layer having apertures that are positioned relative to the input regions of corresponding light guides such that the light emissions propagate through the apertures into the corresponding input regions. The shield layer extends between adjacent apertures and is configured to block the excitation light and the light emissions incident on the shield layer between the adjacent apertures. base toward corresponding light sensors and have a filter material. The device base includes device circuitry electrically coupled to the light sensors and configured to transmit data signals. The biosensor also includes a shield layer having apertures that are positioned relative to the input regions of corresponding light guides such that the light emissions propagate through the apertures into the corresponding input regions. The shield layer extends between adjacent apertures and is configured to block the excitation light and the light emissions incident on the shield layer between the adjacent apertures.
Description
(12) d patent specificaon (19) NZ (11) 759805 (13) B2
(47) Publicaon date: 2021.12.24
(54) Biosensors For Biological Or Chemical Analysis And Methods Of Manufacturing The Same
(51) Internaonal Patent Classificaon(s):
G01N 21/00 G01N 21/62 G01N 21/63 G01N 21/64 B01L 3/00
(22) Filing date: (73) Owner(s):
2014.12.09 ILLUMINA, INC.
(23) te specificaon filing date: (74) Contact:
2014.12.09 Wrays Pty Ltd
(62) Divided out of 720871 (72) Inventor(s):
ZHONG, Cheng, Frank
(30) Internaonal Priority Data: FINKELSTEIN, Hod
US 61/914,275 2013.12.10 V, Boyan
DEHLINGER, Dietrich
SEGALE, Darren
(57) Abstract:
Biosensor including a device base having a sensor array of light sensors and a guide array of
light guides. The light guides have input regions that are configured to receive excitaon light
and light emissions generated by biological or chemical substances. The light guides extend into
the device base toward corresponding light sensors and have a filter material. The device base
includes device circuitry electrically coupled to the light sensors and red to transmit data
signals. The biosensor also includes a shield layer having apertures that are posioned relave to
the input regions of corresponding light guides such that the light emissions propagate through
the apertures into the ponding input regions. The shield layer extends between nt
apertures and is red to block the excitaon light and the light emissions incident on the
shield layer between the adjacent apertures.
759805 B2
WO 89092
BIOSENSORS FOR BIOLOGICAL OR CHEMICAL ANALYSIS AND
METHODS OF MANUFACTURING THE SAME
CROSS-REFERENCE TO RELATED APPLICATIONS
The present application claims the benefit of and priority to US. Provisional
Application No. ,275, filed on December 10, 2013 and having the same title, which
is incorporated herein by reference in its ty.
OUND
Embodiments of the present disclosure relate lly to biological or chemical
analysis and more particularly to systems and methods using detection devices for
biological or chemical analysis.
Various protocols in biological or chemical research involve performing a large
number of controlled reactions on local support surfaces or within ined reaction
chambers. The ated reactions may then be observed or detected and subsequent
analysis may help identify or reveal ties of chemicals involved in the reaction. For
example, in some multiplex assays, an unknown analyte having an identifiable label (e.g.,
fluorescent label) may be exposed to nds of known probes under controlled
conditions. Each known probe may be deposited into a corresponding well of a
microplate. Observing any al reactions that occur between the known probes and
the unknown analyte within the wells may help identify or reveal properties of the analyte.
Other examples of such protocols include known DNA sequencing processes, such as
sequencing-by-synthesis (SBS) or cyclic-array sequencing.
In some conventional fluorescent-detection protocols, an optical system is used
to direct an excitation light onto fluorescently-labeled analytes and to also detect the
fluorescent signals that may emit from the analytes. However, such optical systems can be
relatively ive and require a larger benchtop footprint. For example, the optical
system may include an arrangement of lenses, filters, and light sources. In other proposed
detection systems, the controlled reactions occur immediately over a solid-state imager
(e.g., d-coupled device (CCD) or a complementary metal—oxide—semiconductor
WO 89092
(CMOS) or) that does not require a large l assembly to detect the fluorescent
emissions.
However, the proposed solid-state imaging systems may have some limitations.
For example, it may be challenging to distinguish the fluorescent emissions from the
excitation light when the excitation light is also directed toward the light s of the
solid-state imager. In addition, fluidicly delivering reagents to analytes that are located on
an electronic device and in a controlled manner may present additional challenges. As
r example, fluorescent emissions are substantially isotropic. As the density of the
analytes on the solid-state imager increases, it becomes increasingly challenging to manage
or account for unwanted light emissions from adjacent es (e.g., alk).
BRIEF DESCRIPTION
In an embodiment, a biosensor is provided that includes a flow cell and a
ion device having the flow cell coupled thereto. The flow cell and the detection
device form a flow channel that is configured to have biological or al substances
therein that generate light emissions in response to an excitation light. The detection
device es a device base having a sensor array of light sensors and a guide array of
light guides. The light guides have input regions that are configured to receive the
excitation light and the light emissions from the flow channel. The light guides extend into
the device base from the input regions toward corresponding light sensors and have a filter
material that is configured to filter the excitation light and permit the light emissions to
propagate toward the corresponding light sensors. The device base includes device
circuitry electrically coupled to the light sensors and configured to transmit data signals
based on photons detected by the light sensors. The detection device also includes a shield
layer that extends between the flow l and the device base. The shield layer has
apertures that are positioned ve to the input regions of corresponding light guides
such that the light emissions propagate through the apertures into the corresponding input
s. The shield layer extends between adjacent apertures and is configured to block
the excitation light and the light emissions incident on the shield layer between the
adjacent apertures.
WO 89092
In an embodiment, a biosensor is provided that includes a flow cell and a
detection device having the flow cell coupled thereto. The flow cell and the detection
device form a flow channel that is configured to have biological or chemical substances
n that generate light ons in response to an excitation light. The detection
device may include a device base having a sensor array of light sensors and a guide array
of light guides. The light guides are configured to receive the tion light and the light
emissions fiom the flow l. Each of the light guides extends into the device base
along a central longitudinal axis from an input region of the light guide toward a
corresponding light sensor of the sensor array. The light guides include a filter material
that is configured to filter the excitation light and permit the light emissions to propagate
therethrough toward the corresponding light sensors. The device base includes device
circuitry that is electrically coupled to the light sensors and red to transmit data
signals based on photons detected by the light sensors. The device base includes
peripheral alk shields located therein that surround corresponding light guides of the
guide array. The crosstalk shields at least partially surround the corresponding light guides
about the respective longitudinal axis to reduce optical crosstalk between adjacent light
SGHSOI‘S .
In an embodiment, a method of manufacturing a biosensor is provided. The
method includes providing a device base having a sensor array of light sensors and device
try that is electrically coupled to the light sensors and configured to transmit data
signals based on photons detected by the light sensors. The device base has an outer
surface. The method also includes applying a shield layer to the outer surface of the device
base and forming apertures through the shield layer. The method also es forming
guide cavities that extend from corresponding apertures toward a ponding light
sensor of the sensor array and depositing filter material within the guide cavities. A
portion of the filter material extends along the shield layer. The method also es
curing the filter material and removing the filter material from the shield layer. The filter
material within the guide cavities forms light guides. The method also includes applying a
WO 89092 2014/069373
passivation layer to the shield layer such that the passivation layer s directly along
the shield layer and across the apertures.
In an embodiment, a biosensor is provided that includes a device base having a
sensor array of light sensors and a guide array of light guides. The device base has an
outer surface. The light guides have input regions that are configured to receive excitation
light and light emissions generated by biological or chemical substances proximate to the
outer surface. The light guides extend into the device base from the input regions toward
corresponding light sensors and have a filter material that is configured to filter the
excitation light and permit the light emissions to propagate toward the corresponding light
sensors. The device base es device circuitry electrically coupled to the light sensors
and configured to transmit data signals based on photons detected by the light sensors.
The biosensor also es a shield layer that extends along the outer surface of the device
base. The shield layer has apertures that are positioned relative to the input regions of
corresponding light guides such that the light emissions propagate through the apertures
into the corresponding input regions. The shield layer extends between adjacent apertures
and is configured to block the tion light and the light emissions incident on the shield
layer between the adjacent apertures.
In an embodiment, a biosensor is provided that includes a device base having a
sensor array of light sensors and a guide array of light guides. The device base has an
outer surface. The light guides are configured to receive excitation light and light
emissions generated by biological or chemical substances proximate to the outer surface.
Each of the light guides extends into the device base along a l longitudinal axis from
an input region of the light guide toward a corresponding light sensor of the sensor array.
The light guide es a filter material that is configured to filter the excitation light and
permit the light emissions to propagate therethrough toward corresponding light sensors.
The device base includes device circuitry electrically coupled to the light sensors and
configured to it data signals based on photons detected by the light s. The
device base includes peripheral crosstalk s d therein that surround
corresponding light guides of the guide array. The crosstalk shields at least partially
surrounding the corresponding light guides about the respective longitudinal axis to at least
one of block or reflect errant light rays to reduce optical crosstalk between adjacent light
SGHSOI‘S .
While multiple embodiments are described, still other embodiments of the
described subject matter will become apparent to those skilled in the art from the following
detailed description and gs, which show and describe illustrative embodiments of
disclosed inventive subject . As will be realized, the inventive subject matter is
capable of modifications in various aspects, all without departing from the spirit and scope
of the described subject . Accordingly, the gs and detailed description are to
be regarded as illustrative in nature and not restrictive.
BRIEF PTION OF THE DRAWINGS
Figure l is a block diagram of an exemplary system for biological or al
analysis formed in accordance with one embodiment.
Figure 2 is a block diagram of an exemplary system controller that may be used
in the system of Figure l.
Figure 3 is a block diagram of an exemplary workstation for biological or
al analysis in accordance with one embodiment.
Figure 4 is a perspective view of an exemplary workstation and an ary
cartridge in accordance with one embodiment.
Figure 5 is a front view of an exemplary rack assembly that includes a plurality
of the workstations of Figure 4.
Figure 6 illustrates internal components of an exemplary cartridge.
Figure 7 illustrates a cross-section of a biosensor formed in accordance with one
ment.
Figure 8 is an enlarged portion of the cross-section of Figure 7 illustrating the
biosensor in greater detail.
Figure 9 is another enlarged portion of the cross-section of Figure 7 illustrating
the biosensor in r detail.
Figure 10 is a schematic cross-section of a ion device formed in accordance
with another embodiment.
Figure 11 is a flowchart illustrating a method of manufacturing a biosensor in
accordance with an embodiment.
Figures 12A and 12B illustrate different stages of manufacturing the biosensor of
Figure ll.
DETAILED PTION
ments described herein may be used in s biological or chemical
processes and systems for ic or commercial analysis. More specifically,
embodiments described herein may be used in various processes and systems where it is
desired to detect an event, property, quality, or characteristic that is indicative of a
designated reaction. For example, embodiments described herein include dges,
biosensors, and their components as well as bioassay systems that operate with cartridges
and biosensors. In particular embodiments, the cartridges and sors include a flow
cell and one or more light sensors that are coupled together in a substantially unitary
structure.
The bioassay systems may be configured to perform a plurality of designated
reactions that may be detected individually or collectively. The biosensors and bioassay
systems may be configured to perform us cycles in which the plurality of
designated reactions occurs in parallel. For example, the bioassay systems may be used to
sequence a dense array of DNA features through iterative cycles of enzymatic
manipulation and image acquisition. As such, the dges and biosensors may include
one or more microfiuidic channels that deliver reagents or other reaction components to a
on site. In some embodiments, the reaction sites are randomly buted across a
substantially planer surface. For example, the reaction sites may have an uneven
distribution in which some reaction sites are located closer to each other than other reaction
sites. In other embodiments, the reaction sites are ned across a substantially planer
surface in a predetermined manner. Each of the reaction sites may be associated with one
or more light sensors that detect light from the associated reaction site. Yet in other
embodiments, the on sites are located in reaction chambers that compartmentalize the
designated reactions therein.
The following ed description of certain embodiments will be better
understood when read in conjunction with the appended drawings. To the extent that the
figures illustrate diagrams of the fianctional blocks of various embodiments, the functional
blocks are not necessarily indicative of the division between hardware circuitry. Thus, for
example, one or more of the fianctional blocks (e.g., processors or memories) may be
implemented in a single piece of hardware (e.g., a general purpose signal processor or
random access memory, hard disk, or the like). Similarly, the programs may be stand
alone programs, may be orated as subroutines in an operating system, may be
functions in an installed re package, and the like. It should be understood that the
s embodiments are not d to the arrangements and instrumentality shown in the
drawings.
As used herein, an element or step recited in the singular and proceeded with the
word “a” or “an” should be tood as not excluding plural of said elements or steps,
unless such exclusion is explicitly stated. rmore, references to “one embodiment”
are not ed to be interpreted as excluding the existence of additional embodiments
that also incorporate the d features. Moreover, unless explicitly stated to the
contrary, embodiments “comprising” or “having” an element or a plurality of elements
having a particular ty may include additional elements whether or not they have that
property.
As used herein, a “designated reaction” includes a change in at least one of a
chemical, electrical, physical, or optical property (or quality) of an analyte-of-interest. In
particular embodiments, the ated reaction is a positive binding event (e.g.,
incorporation of a fluorescently labeled biomolecule with the analyte-of-interest). More
lly, the designated reaction may be a chemical transformation, chemical change, or
chemical interaction. The designated reaction may also be a change in electrical
properties. For example, the ated reaction may be a change in ion concentration
within a on. Exemplary reactions include, but are not limited to, chemical reactions
such as reduction, oxidation, addition, elimination, rearrangement, esteriflcation,
amidation, etheriflcation, cyclization, or substitution; binding interactions in which a first
chemical binds to a second chemical; dissociation reactions in which two or more
chemicals detach from each other; fluorescence; scence; bioluminescence;
chemiluminescence; and biological reactions, such as nucleic acid ation, c acid
amplification, nucleic acid hybridization, nucleic acid ligation, phosphorylation, enzymatic
catalysis, receptor binding, or ligand binding. The designated reaction can also be addition
or ation of a proton, for example, detectable as a change in pH of a surrounding
on or environment. An additional designated reaction can be detecting the flow of
ions across a membrane (e. g., natural or synthetic bilayer membrane), for example as ions
flow through a membrane the current is disrupted and the disruption can be detected.
In particular embodiments, the designated reaction includes the incorporation of
a fluorescently-labeled molecule to an analyte. The analyte may be an oligonucleotide and
the fluorescently-labeled molecule may be a nucleotide. The ated reaction may be
ed when an excitation light is directed toward the oligonucleotide having the labeled
nucleotide, and the fluorophore emits a detectable fluorescent . In ative
embodiments, the detected fluorescence is a result of uminescence or
bioluminescence. A designated reaction may also increase fluorescence (or Forster)
resonance energy transfer (FRET), for example, by bringing a donor fluorophore in
proximity to an acceptor fluorophore, decrease FRET by separating donor and acceptor
fluorophores, increase fluorescence by separating a quencher from a fluorophore or
decrease fluorescence by co-locating a quencher and fluorophore.
As used herein, a “reaction ent” or ant” includes any substance that
may be used to obtain a ated reaction. For example, reaction components include
reagents, enzymes, samples, other biomolecules, and buffer solutions. The reaction
components are typically delivered to a reaction site in a on and/or immobilized at a
reaction site. The reaction components may interact directly or indirectly with another
nce, such as the analyte-of-interest.
As used herein, the term “reaction site” is a localized region where a designated
reaction may occur. A reaction site may include support surfaces of a substrate where a
substance may be immobilized thereon. For example, a reaction site may include a
substantially planar surface in a channel of a flow cell that has a colony of nucleic acids
thereon. lly, but not always, the nucleic acids in the colony have the same
sequence, being for example, clonal copies of a single ed or double ed
template. However, in some ments a reaction site may contain only a single
nucleic acid le, for example, in a single stranded or double stranded form.
Furthermore, a plurality of on sites may be randomly distributed along the support
surface or arranged in a predetermined manner (e.g., side-by-side in a matrix, such as in
microarrays). A reaction site can also include a reaction chamber that at least lly
defines a spatial region or volume configured to compartmentalize the designated reaction.
As used herein, the term “reaction chamber” includes a spatial region that is in fluid
communication with a flow channel. The reaction chamber may be at least partially
separated from the surrounding environment or other spatial regions. For example, a
plurality of reaction chambers may be separated from each other by shared walls. As a
more specific example, the reaction chamber may include a cavity defined by interior
surfaces of a well and have an opening or aperture so that the cavity may be in fluid
communication with a flow channel. sors including such reaction chambers are
described in r detail in international application no. PCT/USZOl 1/0571 1 I, filed on
October 20, 2011, which is incorporated herein by reference in its entirety.
In some embodiments, the reaction chambers are sized and shaped relative to
solids (including semi-solids) so that the solids may be inserted, fully or partially, therein.
For example, the reaction chamber may be sized and shaped to accommodate only one
capture bead. The capture bead may have clonally amplified DNA or other nces
thereon. Alternatively, the on r may be sized and shaped to receive an
approximate number of beads or solid substrates. As another example, the reaction
PCT/USZOl4/069373
rs may also be filled with a porous gel or substance that is configured to l
diffusion or filter fluids that may flow into the on chamber.
In some embodiments, light sensors (e.g., photodiodes) are associated with
corresponding reaction sites. A light sensor that is associated with a reaction site is
configured to detect light emissions from the associated reaction site when a designated
reaction has occurred at the associated reaction site. In some cases, a plurality of light
sensors (e.g. several pixels of a camera deVice) may be associated with a single reaction
site. In other cases, a single light sensor (e.g. a single pixel) may be associated with a
single reaction site or with a group of reaction sites. The light sensor, the reaction site, and
other features of the biosensor may be red so that at least some of the light is
directly detected by the light sensor without being ed.
As used herein, the term “adjacent” when used with respect to two reaction sites
means no other reaction site is located between the two reaction sites. The term “adjacent”
may have a r meaning when used with respect to adjacent detection paths and
adjacent light sensors (e. g., adjacent light s have no other light sensor etween).
In some cases, a reaction site may not be adjacent to another reaction site, but may still be
within an immediate Vicinity of the other reaction site. A first reaction site may be in the
immediate Vicinity of a second reaction site when fluorescent emission signals from the
first reaction site are ed by the light sensor associated with the second reaction site.
More specifically, a first reaction site may be in the immediate Vicinity of a second
reaction site when the light sensor associated with the second reaction site detects, for
example crosstalk from the first reaction site. Adjacent reaction sites can be contiguous
such that they abut each other or the nt sites can be non-contiguous haVing an
intervening space between.
As used herein, a “substance” includes items or solids, such as capture beads, as
well as biological or chemical substances. As used herein, a “biological or chemical
substance” includes biomolecules, s-of—interest, analytes-of-interest, and other
chemical compound(s). A biological or chemical substance may be used to detect,
identify, or e other chemical compound(s), or function as intermediaries to study or
2014/069373
analyze other chemical compound(s). In particular embodiments, the biological or
chemical substances include a biomolecule. As used herein, a “biomolecule” includes at
least one of a biopolymer, nucleoside, nucleic acid, polynucleotide, oligonucleotide,
protein, enzyme, ptide, antibody, antigen, ligand, receptor, polysaccharide,
carbohydrate, osphate, cell, , organism, or fragment thereof or any other
biologically active chemical compound(s) such as analogs or mimetics of the
aforementioned species.
In a fiarther example, a biological or chemical substance or a biomolecule
includes an enzyme or reagent used in a d reaction to detect the t of another
reaction such as an enzyme or reagent used to detect pyrophosphate in a pyrosequencing
reaction. Enzymes and reagents useful for osphate detection are described, for
e, in US. Patent ation No. 244870 A1, which is incorporated herein in
its entirety.
Biomolecules, samples, and biological or chemical substances may be naturally
ing or synthetic and may be suspended in a solution or mixture within a spatial
region. Biomolecules, samples, and biological or chemical substances may also be bound
to a solid phase or gel material. Biomolecules, samples, and biological or chemical
substances may also include a pharmaceutical composition. In some cases, biomolecules,
samples, and biological or chemical substances of interest may be referred to as targets,
probes, or analytes.
As used herein, a “biosensor” includes a structure having a plurality of reaction
sites that is configured to detect designated reactions that occur at or proximate to the
reaction sites. A biosensor may include a solid-state imaging device (e.g., CCD or CMOS
imager) and, optionally, a flow cell mounted thereto. The flow cell may include at least
one flow channel that is in fluid communication with the reaction sites. As one specific
example, the biosensor is configured to fluidicly and electrically couple to a bioassay
system. The bioassay system may deliver nts to the reaction sites according to a
predetermined protocol (e. g., sequencing-by-synthesis) and m a ity of imaging
. For example, the bioassay system may direct solutions to flow along the reaction
PCT/U82014/069373
sites. At least one of the solutions may include four types of nucleotides having the same
or different fluorescent labels. The nucleotides may bind to corresponding
oligonucleotides located at the reaction sites. The bioassay system may then illuminate the
reaction sites using an tion light source (e. g., solid-state light sources, such as light-
emitting diodes or LEDs). The excitation light may have a predetermined wavelength or
ngths, including a range of ngths. The excited fluorescent labels provide
emission signals that may be detected by the light sensors.
In alternative embodiments, the biosensor may include odes or other types
of sensors red to detect other identifiable ties. For e, the sensors may
be configured to detect a change in ion concentration. In r example, the sensors may
be configured to detect the ion current flow across a membrane
As used herein, a “cartridge” includes a structure that is configured to hold a
biosensor. In some embodiments, the cartridge may include additional features, such as
the light source (e.g., LEDs) that are configured to provide excitation light to the reactions
sites of the biosensor. The cartridge may also include a fluidic storage system (e.g.,
storage for reagents, sample, and buffer) and a fluidic control system (e. g., pumps, valves,
and the like) for fiuidically transporting on components, sample, and the like to the
on sites. For example, after the biosensor is prepared or manufactured, the biosensor
may be coupled to a housing or container of the cartridge. In some embodiments, the
biosensors and the cartridges may be self-contained, disposable units. However, other
embodiments may include an assembly with removable parts that allow a user to access an
interior of the biosensor or cartridge for maintenance or ement of components or
samples. The biosensor and the cartridge may be removably coupled or engaged to larger
bioassay systems, such as a sequencing system, that conducts controlled reactions n.
As used herein, when the terms “removably” and “coupled” (or “engaged”) are
used together to describe a relationship between the biosensor (or cartridge) and a system
receptacle or interface of a bioassay , the term is intended to mean that a tion
between the biosensor (or cartridge) and the system receptacle is readily separable without
destroying or damaging the system acle and/or the biosensor (or cartridge).
PCT/U82014/069373
ents are readily separable when the components may be ted from each other
without undue effort or a significant amount of time spent in separating the components.
For e, the biosensor (or cartridge) may be removably coupled or engaged to the
system receptacle in an electrical manner such that the mating contacts of the bioassay
system are not destroyed or damaged. The biosensor (or cartridge) may also be removably
coupled or engaged to the system receptacle in a mechanical manner such that the features
that hold the biosensor (or cartridge) are not destroyed or damaged. The biosensor (or
cartridge) may also be removably coupled or engaged to the system receptacle in a fluidic
manner such that the ports of the system receptacle are not destroyed or damaged. The
system receptacle or a component is not considered to be destroyed or damaged if, for
example, only a simple adjustment to the component (e.g., realignment) or a simple
ement (e. g., replacing a nozzle) is required.
As used herein, the term “fluid communication” or “fluidicly coupled” refers to
two spatial regions being connected together such that a liquid or gas may flow between
the two spatial regions. For example, a microfluidic channel may be in fluid
communication with a reaction chamber such that a fluid may flow freely into the reaction
chamber from the microfluidic channel. The terms “in fluid communication” or “fluidicly
coupled” allow for two spatial regions being in fluid communication through one or more
valves, restrictors, or other fluidic ents that are configured to l or regulate a
flow of fluid through a system.
As used herein, the term “immobilized,” when used with respect to a
ecule or biological or chemical substance, includes substantially attaching the
ecule or biological or chemical substance at a molecular level to a surface. For
example, a biomolecule or ical or chemical substance may be immobilized to a
surface of the substrate material using adsorption techniques including non-covalent
interactions (e.g., ostatic forces, van der Waals, and ation of hydrophobic
interfaces) and nt binding techniques where flinctional groups or linkers facilitate
attaching the biomolecules to the surface. Immobilizing biomolecules or biological or
chemical substances to a surface of a substrate material may be based upon the properties
PCT/USZOl4/069373
of the substrate surface, the liquid medium carrying the biomolecule or biological or
chemical substance, and the properties of the biomolecules or biological or chemical
substances themselves. In some cases, a substrate e may be onalized (e.g.,
chemically or physically d) to facilitate immobilizing the ecules (or
ical or chemical nces) to the substrate surface. The substrate surface may be
first modified to have functional groups bound to the surface. The functional groups may
then bind to biomolecules or biological or chemical substances to immobilize them
thereon. A substance can be immobilized to a surface Via a gel, for example, as described
in US Patent Publ. No. US 2011/0059865 A1, which is incorporated herein by reference.
In some embodiments, nucleic acids can be attached to a surface and amplified
using bridge amplification. Useful bridge amplification methods are described, for
example, in US. Patent No. 658; WO 07/010251, US. Pat. No. 6,090,592; US.
Patent Publ. No. 2002/0055100 A1; US. Patent No. 7,115,400; US. Patent Publ. No.
2004/0096853 A1; US. Patent Publ. No. 2004/0002090 A1; US. Patent Publ. No.
2007/0128624 A1; and US. Patent Publ. No. 2008/0009420 A1, each of which is
incorporated herein in its entirety. Another useful method for amplifying nucleic acids on
a surface is rolling circle amplification (RCA), for example, using methods set forth in
further detail below. In some embodiments, the nucleic acids can be attached to a surface
and amplified using one or more primer pairs. For example, one of the primers can be in
solution and the other primer can be immobilized on the e (e.g., ached). By
way of example, a nucleic acid molecule can hybridize to one of the primers on the surface
followed by extension of the lized primer to produce a first copy of the nucleic
acid. The primer in solution then hybridizes to the first copy of the nucleic acid which can
be extended using the first copy of the nucleic acid as a template. Optionally, after the first
copy of the nucleic acid is produced, the original nucleic acid molecule can hybridize to a
second lized primer on the surface and can be extended at the same time or after
the primer in solution is extended. In any embodiment, repeated rounds of extension (e. g.,
amplification) using the immobilized primer and primer in solution provide le copies
of the nucleic acid.
W0 2015/089092 PCT/U82014/069373
In particular embodiments, the assay protocols executed by the systems and
methods described herein include the use of natural tides and also enzymes that are
configured to interact with the l nucleotides. l nucleotides include, for
example, ribonucleotides or deoxyribonucleotides. Natural nucleotides can be in the
mono-, di-, or tri-phosphate form and can have a base selected from adenine (A), Thymine
(T), uracil (U), guanine (G) or ne (C). It will be understood however that non-natural
nucleotides, modified nucleotides or s of the aforementioned nucleotides can be
used. Some examples of useful non-natural nucleotides are set forth below in regard to
reversible terminator-based sequencing by synthesis s.
In embodiments that e reaction chambers, items or solid substances
(including semi-solid substances) may be disposed within the reaction chambers. When
disposed, the item or solid may be physically held or immobilized within the reaction
chamber through an interference fit, adhesion, or entrapment. Exemplary items or solids
that may be disposed within the reaction chambers include polymer beads, pellets, agarose
gel, powders, quantum dots, or other solids that may be compressed and/or held within the
reaction chamber. In ular embodiments, a nucleic acid superstructure, such as a
DNA ball, can be disposed in or at a reaction chamber, for example, by attachment to an
interior surface of the on chamber or by residence in a liquid within the reaction
chamber. A DNA ball or other nucleic acid superstructure can be preformed and then
disposed in or at the reaction chamber. atively, a DNA ball can be synthesized in
situ at the reaction chamber. A DNA ball can be synthesized by rolling circle
amplification to produce a concatamer of a particular c acid sequence and the
concatamer can be treated with conditions that form a relatively compact ball. DNA balls
and methods for their synthesis are described, for example in, US. Patent Publ. Nos.
2008/0242560 Al or 2008/0234136 Al, each of which is incorporated herein in its
entirety. A substance that is held or disposed in a reaction chamber can be in a solid,
liquid, or gaseous state.
Figure l is a block m of an exemplary bioassay system 100 for biological
or chemical analysis formed in accordance with one embodiment. The term “bioassay” is
PCT/U82014/069373
not ed to be limiting as the bioassay system 100 may operate to obtain any
information or data that relates to at least one of a biological or chemical substance. In
some embodiments, the bioassay system 100 is a workstation that may be similar to a
bench-top device or desktop computer. For example, a majority (or all) of the systems and
ents for conducting the designated reactions can be within a common housing 116.
In particular embodiments, the bioassay system 100 is a nucleic acid sequencing
system (or sequencer) configured for various applications, including but not limited to de
novo sequencing, resequencing of whole genomes or target genomic regions, and
nomics. The sequencer may also be used for DNA or RNA analysis. In some
ments, the ay system 100 may also be configured to generate reaction sites in
a biosensor. For example, the bioassay system 100 may be configured to receive a sample
and generate surface attached clusters of clonally amplified nucleic acids derived from the
sample. Each r may constitute or be part of a reaction site in the biosensor.
The exemplary ay system 100 may e a system receptacle or interface
112 that is red to interact with a biosensor 102 to perform designated reactions
within the biosensor 102. In the following description with respect to Figure 1, the
biosensor 102 is loaded into the system receptacle 112. However, it is understood that a
cartridge that includes the biosensor 102 may be ed into the system receptacle 112
and in some states the cartridge can be removed temporarily or permanently. As described
above, the cartridge may include, among other things, fiuidic control and fluidic storage
components.
In particular embodiments, the bioassay system 100 is configured to perform a
large number of parallel reactions within the biosensor 102. The biosensor 102 es
one or more reaction sites where designated reactions can occur. The reaction sites may
be, for example, immobilized to a solid e of the biosensor or immobilized to beads
(or other movable substrates) that are located within corresponding on chambers of
the biosensor. The reaction sites can include, for example, clusters of clonally amplified
nucleic acids. The biosensor 102 may include a solid-state imaging device (e.g., CCD or
CMOS imager) and a flow cell d thereto. The flow cell may include one or more
W0 2015/089092
flow channels that receive a solution from the bioassay system 100 and direct the solution
toward the on sites. Optionally, the biosensor 102 can be configured to engage a
thermal element for transferring thermal energy into or out of the flow channel.
The bioassay system 100 may include various components, assemblies, and
systems (or sub-systems) that interact with each other to perform a ermined method
or assay ol for biological or chemical analysis. For e, the bioassay system
100 includes a system controller 104 that may communicate with the various components,
assemblies, and sub-systems of the ay system 100 and also the biosensor 102. For
example, in on to the system receptacle 112, the bioassay system 100 may also
include a fluidic control system 106 to control the flow of fluid throughout a fluid network
of the bioassay system 100 and the biosensor 102; a fluid storage system 108 that is
configured to hold all fluids (e. g., gas or liquids) that may be used by the bioassay system;
a temperature control system 110 that may regulate the ature of the fluid in the fluid
network, the fluid storage system 108, and/or the biosensor 102; and an illumination
system 111 that is configured to illuminate the biosensor 102. As described above, if a
cartridge having the biosensor 102 is loaded into the system receptacle 112, the cartridge
may also include fluidic control and fluidic storage components.
Also shown, the bioassay system 100 may include a user interface 114 that
interacts with the user. For example, the user interface 114 may include a display 113 to
y or request information fiom a user and a user input device 115 to receive user
inputs. In some embodiments, the display 113 and the user input device 115 are the same
device. For example, the user interface 114 may include a touch-sensitive display
configured to detect the presence of an individual's touch and also identify a location of the
touch on the display. However, other user input devices 115 may be used, such as a
mouse, touchpad, keyboard, keypad, handheld scanner, voice-recognition system, motion-
recognition system, and the like. As will be discussed in r detail below, the bioassay
system 100 may communicate with various components, including the biosensor 102 (e. g.
in the form of a cartridge), to perform the ated reactions. The bioassay system 100
may also be configured to analyze data obtained from the biosensor to provide a user with
PCT/U82014/069373
desired ation.
The system controller 104 may include any processor-based or microprocessorbased
system, including systems using microcontrollers, reduced instruction set computers
(RISC), application specific integrated circuits (ASICs), field programmable gate array
(FPGAs), logic circuits, and any other circuit or processor capable of executing functions
described herein. The above examples are ary only, and are thus not intended to
limit in any way the definition and/or g of the term system controller. In the
exemplary embodiment, the system controller 104 executes a set of instructions that are
stored in one or more storage elements, memories, or modules in order to at least one of
obtain and analyze detection data. Storage ts may be in the form of information
sources or physical memory elements within the ay system 100.
The set of instructions may include s commands that instruct the bioassay
system 100 or biosensor 102 to perform specific operations such as the methods and
processes of the various embodiments described . The set of instructions may be in
the form of a software m, which may form part of a tangible, non-transitory
computer readable medium or media. As used herein, the terms “software” and
“firmware” are interchangeable, and include any computer program stored in memory for
execution by a computer, including RAM memory, ROM memory, EPROM memory,
EEPROM memory, and latile RAM (NVRAM) memory. The above memory types
are exemplary only, and are thus not limiting as to the types of memory usable for storage
of a computer m.
The software may be in various forms such as system software or application
software. Further, the software may be in the form of a collection of separate programs, or
a program module within a larger program or a portion of a program module. The
re also may include r programming in the form of obj ect-oriented
programming. After obtaining the detection data, the detection data may be automatically
processed by the bioassay system 100, processed in response to user inputs, or processed in
se to a request made by another processing machine (e. g., a remote request through
a communication link).
The system controller 104 may be connected to the biosensor 102 and the other
components of the bioassay system 100 via ication links. The system controller
104 may also be communicatively connected to off-site systems or servers. The
communication links may be hardwired or wireless. The system controller 104 may
receive user inputs or commands, from the user interface 114 and the user input device
115.
The fluidic control system 106 es a fluid network and is configured to
direct and regulate the flow of one or more fluids through the fluid network. The fluid
network may be in fluid communication with the biosensor 102 and the fluid storage
system 108. For example, select fluids may be drawn from the fluid e system 108
and directed to the biosensor 102 in a controlled manner, or the fluids may be drawn from
the biosensor 102 and directed toward, for example, a waste reservoir in the fluid storage
system 108. Although not shown, the fluidic control system 106 may include flow sensors
that detect a flow rate or pressure of the fluids within the fluid network. The sensors may
communicate with the system controller 104.
The temperature control system 110 is configured to regulate the temperature of
fluids at different regions of the fluid network, the fluid e system 108, and/or the
sor 102. For example, the ature l system 110 may include a
thermocycler that interfaces with the sor 102 and controls the ature of the
fluid that flows along the reaction sites in the biosensor 102. The temperature control
system 110 may also regulate the temperature of solid elements or components of the
bioassay system 100 or the biosensor 102. Although not shown, the temperature control
system 110 may include sensors to detect the temperature of the fluid or other components.
The sensors may communicate with the system ller 104.
The fluid storage system 108 is in fluid communication with the biosensor 102
and may store various reaction components or reactants that are used to conduct the
designated reactions therein. The fluid e system 108 may also store fluids for
washing or cleaning the fluid network and biosensor 102 and for diluting the reactants.
For example, the fluid storage system 108 may include various reservoirs to store samples,
PCT/USZOl4/069373
reagents, enzymes, other biomolecules, buffer solutions, aqueous, and non-polar ons,
and the like. Furthermore, the fluid storage system 108 may also include waste reservoirs
for receiving waste ts from the biosensor 102. In embodiments that include a
cartridge, the cartridge may include one or more of a fluid storage system, fluidic control
system or temperature control system. Accordingly, one or more of the components set
forth herein as relating to those systems can be contained within a cartridge housing. For
example, a dge can have various reservoirs to store samples, reagents, enzymes, other
biomolecules, buffer solutions, aqueous, and non-polar solutions, waste, and the like. As
such, one or more of a fluid storage system, fluidic control system or temperature control
system can be removably engaged with a bioassay system via a cartridge or other
biosensor.
The illumination system 111 may include a light source (e.g., one or more LEDs)
and a plurality of optical components to illuminate the biosensor. Examples of light
sources may include , arc lamps, LEDs, or laser diodes. The optical components may
be, for example, reflectors, dichroics, beam splitters, collimators, lenses, filters, wedges,
prisms, mirrors, detectors, and the like. In embodiments that use an illumination system,
the illumination system 111 may be configured to direct an excitation light to reaction
sites. As one example, fluorophores may be d by green wavelengths of light, as such
the wavelength of the excitation light may be approximately 532 nm.
The system receptacle or interface 112 is configured to engage the biosensor 102
in at least one of a mechanical, electrical, and fluidic . The system receptacle 112
may hold the biosensor 102 in a d ation to tate the flow of fluid through
the biosensor 102. The system receptacle 112 may also e electrical contacts that are
configured to engage the biosensor 102 so that the bioassay system 100 may icate
with the biosensor 102 and/or provide power to the biosensor 102. Furthermore, the
system receptacle 112 may include fluidic ports (e. g., nozzles) that are configured to
engage the biosensor 102. In some embodiments, the biosensor 102 is removably d
to the system receptacle 112 in a mechanical manner, in an electrical manner, and also in a
fluidic manner.
PCT/USZOl4/069373
In addition, the bioassay system 100 may communicate remotely with other
systems or networks or with other bioassay systems 100. Detection data obtained by the
bioassay system(s) 100 may be stored in a remote database.
Figure 2 is a block diagram of the system controller 104 in the exemplary
embodiment. In one embodiment, the system controller 104 es one or more
processors or modules that can communicate with one another. Each of the processors or
modules may include an algorithm (e.g., instructions stored on a tangible and/or non-
transitory computer readable storage medium) or sub-algorithms to m ular
processes. The system controller 104 is illustrated conceptually as a collection of modules,
but may be implemented utilizing any combination of dedicated re boards, DSPs,
processors, etc. Alternatively, the system controller 104 may be implemented utilizing an
e-shelf PC with a single processor or multiple processors, with the fianctional
operations distributed between the processors. As a further option, the modules described
below may be implemented utilizing a hybrid configuration in which certain modular
functions are performed ing dedicated hardware, while the remaining modular
ons are performed utilizing an off-the-shelf PC and the like. The modules also may
be ented as software modules within a sing unit.
During operation, a communication link 120 may transmit information (e.g.
commands) to or receive information (e.g. data) from the biosensor 102 (Figure 1) and/or
the sub-systems 106, 108, 110 (Figure 1). A communication link 122 may receive user
input from the user interface 114 (Figure 1) and transmit data or information to the user
ace 114. Data from the biosensor 102 or sub-systems 106, 108, 110 may be
processed by the system controller 104 in real-time during a bioassay session.
Additionally or alternatively, data may be stored arily in a system memory during a
ay session and processed in slower than real-time or off-line operation.
As shown in Figure 2, the system controller 104 may include a plurality of
modules 131-139 that communicate with a main control module 130. The main control
module 130 may communicate with the user interface 114 (Figure 1). Although the
modules 131-139 are shown as icating directly with the main control module 130,
the modules 131-139 may also communicate directly with each other, the user ace
114, and the biosensor 102. Also, the modules 131-139 may communicate with the main
control module 130 through the other modules.
The plurality of modules 131-139 include system modules 131-133, 139 that
communicate with the sub-systems 106, 108, 110, and 111, respectively. The fluidic
control module 131 may communicate with the fluidic control system 106 to control the
valves and flow sensors of the fluid network for controlling the flow of one or more fluids
h the fluid network. The fluid e module 132 may notify the user when fluids
are low or when the waste reservoir is at or near capacity. The fluid storage module 132
may also communicate with the temperature control module 133 so that the fluids may be
stored at a desired ature. The illumination module 139 may communicate with the
illumination system 109 to illuminate the reaction sites at designated times during a
protocol, such as after the designated ons (e.g., binding events) have occurred.
The ity of modules 131-139 may also include a device module 134 that
communicates with the biosensor 102 and an identification module 135 that determines
fication information relating to the biosensor 102. The device module 134 may, for
e, communicate with the system receptacle 112 to confirm that the biosensor has
established an electrical and fluidic connection with the bioassay system 100. The
identification module 135 may receive signals that identify the biosensor 102. The
identification module 135 may use the identity of the biosensor 102 to provide other
information to the user. For example, the identification module 135 may determine and
then display a lot number, a date of manufacture, or a protocol that is recommended to be
run with the biosensor 102.
The plurality of modules 131-139 may also include a detection data analysis
module 138 that receives and analyzes the signal data (e.g., image data) from the sor
102. The signal data may be stored for subsequent analysis or may be transmitted to the
user interface 114 to display d information to the user. In some embodiments, the
signal data may be processed by the solid-state imager (e.g., CMOS image sensor) before
the detection data is module 138 receives the signal data.
PCT/USZOl4/069373
Protocol modules 136 and 137 communicate with the main control module 130
to control the operation of the sub-systems 106, 108, and 110 when conducting
predetermined assay protocols. The protocol modules 136 and 137 may include sets of
instructions for instructing the bioassay system 100 to perform specific operations pursuant
to predetermined protocols. As shown, the protocol module may be a sequencing-by-
synthesis (SBS) module 136 that is configured to issue various commands for performing
sequencing-by-synthesis processes. In SBS, extension of a c acid primer along a
nucleic acid template is monitored to ine the sequence of tides in the
template. The underlying chemical process can be polymerization (e.g. as catalyzed by a
polymerase enzyme) or ligation (e.g. zed by a ligase enzyme). In a ular
polymerase-based SBS ment, fluorescently labeled nucleotides are added to a
primer (thereby extending the primer) in a template dependent fashion such that detection
of the order and type of nucleotides added to the primer can be used to determine the
sequence of the template. For example, to initiate a first SBS cycle, commands can be
given to r one or more labeled nucleotides, DNA polymerase, etc., into/through a
flow cell that houses an array of c acid templates. The nucleic acid templates may be
located at corresponding reaction sites. Those reaction sites where primer extension causes
a labeled nucleotide to be incorporated can be detected through an imaging event. During
an imaging event, the illumination system 111 may provide an tion light to the
reaction sites. Optionally, the nucleotides can fiarther include a reversible termination
property that terminates further primer extension once a nucleotide has been added to a
primer. For example, a nucleotide analog having a reversible terminator moiety can be
added to a primer such that subsequent extension cannot occur until a deblocking agent is
red to remove the . Thus, for embodiments that use reversible termination a
command can be given to deliver a deblocking reagent to the flow cell (before or after
detection ). One or more commands can be given to effect wash(es) between the
various delivery steps. The cycle can then be repeated 11 times to extend the primer by 11
nucleotides, thereby detecting a ce of length n. Exemplary sequencing techniques
are described, for e, in Bentley et al., Nature 456:53-59 (2008), WC 04/018497; US
7,057,026; WO 91/06678; WO 07/123744; US 7,329,492; US 7,211,414; US 7,315,019;
PCT/USZOl4/069373
US 7,405,281, and US 2008/0108082, each of which is incorporated herein by reference.
For the nucleotide delivery step of an SBS cycle, either a single type of
nucleotide can be delivered at a time, or multiple different tide types (e.g. A, C, T
and G together) can be delivered. For a nucleotide delivery configuration where only a
single type of nucleotide is present at a time, the different nucleotides need not have
distinct labels since they can be distinguished based on temporal separation inherent in the
individualized delivery. Accordingly, a sequencing method or apparatus can use single
color ion. For example, an excitation source need only provide excitation at a single
ngth or in a single range of wavelengths. For a nucleotide delivery configuration
where delivery s in multiple different nucleotides being present in the flow cell at one
time, sites that incorporate different nucleotide types can be distinguished based on
ent fluorescent labels that are attached to respective nucleotide types in the mixture.
For example, four different nucleotides can be used, each having one of four different
fluorophores. In one embodiment, the four different fluorophores can be distinguished
using excitation in four different regions of the spectrum. For example, four different
excitation radiation s can be used. Alternatively, fewer than four different excitation
sources can be used, but optical filtration of the excitation ion from a single source
can be used to produce different ranges of excitation radiation at the flow cell.
In some embodiments, fewer than four ent colors can be detected in a
mixture having four different nucleotides. For example, pairs of nucleotides can be
detected at the same wavelength, but distinguished based on a difference in intensity for
one member of the pair compared to the other, or based on a change to one member of the
pair (e. g. via al modification, photochemical modification or physical modification)
that causes apparent signal to appear or disappear compared to the signal detected for the
other member of the pair. Exemplary tus and methods for distinguishing four
ent nucleotides using detection of fewer than four colors are described for example in
US Pat. App. Ser. Nos. 61/538,294 and 61/619,878, which are incorporated herein by
reference their entireties. US. Application No. 13/624,200, which was filed on September
21, 2012, is also incorporated by nce in its entirety.
W0 2015/089092
The plurality of protocol modules may also e a sample-preparation (or
generation) module 137 that is configured to issue commands to the fluidic control system
106 and the temperature control system 110 for amplifying a product within the biosensor
102. For example, the biosensor 102 may be engaged to the bioassay system 100. The
amplification module 137 may issue ctions to the fluidic control system 106 to
deliver ary amplification components to reaction chambers within the biosensor 102.
In other embodiments, the reaction sites may y n some components for
amplification, such as the template DNA and/or primers. After delivering the
amplification components to the reaction chambers, the amplification module 137 may
instruct the temperature control system 110 to cycle through different temperature stages
ing to known amplification protocols. In some embodiments, the amplification
and/or nucleotide incorporation is performed isothermally.
The SBS module 136 may issue commands to perform bridge PCR where
clusters of clonal amplicons are formed on localized areas within a channel of a flow cell.
After ting the amplicons through bridge PCR, the amplicons may be “linearized” to
make single stranded template DNA, or sstDNA, and a cing primer may be
hybridized to a universal sequence that flanks a region of interest. For example, a
reversible terminator-based sequencing by synthesis method can be used as set forth above
or as follows.
Each sequencing cycle can extend a sstDNA by a single base which can be
accomplished for example by using a modified DNA polymerase and a mixture of four
types of nucleotides. The different types of nucleotides can have unique fluorescent labels,
and each nucleotide can r have a reversible ator that allows only a single-base
incorporation to occur in each cycle. After a single base is added to the sstDNA, excitation
light may be incident upon the reaction sites and fluorescent emissions may be detected.
After detection, the fluorescent label and the terminator may be chemically cleaved from
the sstDNA. Another similar sequencing cycle may follow. In such a cing
ol, the SBS module 136 may instruct the fluidic control system 106 to direct a flow
of reagent and enzyme solutions through the biosensor 102. Exemplary reversible
PCT/USZOl4/069373
terminator-based SBS methods which can be utilized with the apparatus and methods set
forth herein are described in US Patent ation Publication No. 2007/0166705 A1, US
Patent Application ation No. 2006/0188901 Al, US Patent No. 7,057,026, US Patent
ation Publication No. 2006/0240439 A1, US Patent Application Publication No.
2006/0281109 Al, PCT Publication No. WO 814, US Patent Application
Publication No. 2005/0100900 A1, PCT Publication No. WO 06/064199 and PCT
Publication No. WO 07/010251, each of which is incorporated herein by reference in its
entirety. Exemplary reagents for reversible terminator-based SBS are described in US
7,541,444; US 7,057,026; US 7,414,116; US 7,427,673; US 7,566,537; US 7,592,435 and
W0 07/135368, each of which is incorporated herein by reference in its entirety.
In some embodiments, the amplification and SBS modules may operate in a
single assay protocol where, for example, template c acid is amplified and
subsequently sequenced within the same cartridge.
The bioassay system 100 may also allow the user to reconfigure an assay
protocol. For example, the bioassay system 100 may offer options to the user through the
user interface 114 for modifying the determined protocol. For example, if it is ined
that the biosensor 102 is to be used for amplification, the bioassay system 100 may request
a temperature for the annealing cycle. Furthermore, the ay system 100 may issue
warnings to a user if a user has provided user inputs that are generally not able for
the selected assay protocol.
Figure 3 is a block diagram of an exemplary workstation 200 for biological or
chemical is in accordance with one embodiment. The workstation 200 may have
similar features, systems, and assemblies as the bioassay system 100 bed above. For
example, the workstation 200 may have a fluidic control system, such as the fluidic control
system 106 (Figure 1), that is fluidicly d to a biosensor (or cartridge) 235 h a
fluid network 238. The fluid network 238 may include a reagent cartridge 240, a valve
block 242, a main pump 244, a debubbler 246, a 3-way valve 248, a flow restrictor 250, a
waste removal system 252, and a purge pump 254. In particular embodiments, most of the
components or all of the components described above are within a common workstation
W0 2015/089092
housing (not shown). gh not shown, the workstation 200 may also include an
illumination system, such as the illumination system 111, that is configured to provide an
excitation light to the reaction sites.
A flow of fluid is indicated by arrows along the fluid network 238. For example,
t solutions may be removed from the reagent dge 240 and flow through the
valve block 242. The valve block 242 may facilitate creating a zero-dead volume of the
fluid flowing to the dge 235 from the reagent cartridge 240. The valve block 242 can
select or permit one or more liquids within the reagent cartridge 240 to flow through the
fluid network 238. For example, the valve block 242 can include solenoid valves that have
a compact arrangement. Each solenoid valve can control the flow of a fluid from a single
reservoir bag. In some embodiments, the valve block 242 can permit two or more different
liquids to flow into the fluid network 238 at the same time y mixing the two or more
different liquids. After leaving the valve block 242, the fluid may flow through the main
pump 244 and to the debubbler 246. The debubbler 246 is configured to remove unwanted
gases that have entered or been generated within the fluid network 238.
From the debubbler 246, fluid may flow to the 3-way valve 248 where the fluid
is either directed to the cartridge 235 or bypassed to the waste removal system 252. A
flow of the fluid within the cartridge 235 may be at least partially controlled by the flow
restrictor 250 located downstream from the cartridge 235. Furthermore, the flow restrictor
250 and the main pump 244 may coordinate with each other to control the flow of fluid
across reaction sites and/or l the pressure within the fluid network 238. Fluid may
flow h the cartridge 235 and onto the waste removal system 252. Optionally, fluid
may flow through the purge pump 254 and into, for e, a waste reservoir bag within
the t cartridge 240.
Also shown in Figure 3, the workstation 200 may include a temperature control
, such as the ature control system 110, that is configured to regulate or
control a thermal environment of the different components and sub-systems of the
workstation 200. The temperature control system 110 can include a reagent cooler 264
that is configured to control the temperature requirements of various fluids used by the
PCT/USZOl4/069373
workstation 200, and a thermocycler 266 that is configured to control the ature of a
cartridge 235. The thermocycler 266 can e a thermal element (not shown) that
interfaces with the cartridge.
Furthermore, the workstation 200 may include a system controller or SBS board
260 that may have similar features as the system controller 104 described above. The SBS
board 260 may communicate with the various components and sub-systems of the
ation 200 as well as the cartridge 235. Furthermore, the SBS board 260 may
communicate with remote systems to, for e, store data or receive commands from
the remote systems. The workstation 200 may also include a touch screen user interface
262 that is operatively coupled to the SBS board 260 through a single-board computer
(SEC) 272. The workstation 200 may also include one or more user accessible data
communication ports and/or drives. For example a workstation 200 may include one or
more sal serial bus (USB) connections for computer peripherals, such as a flash or
jump drive, a compact-flash (CF) drive and/or a hard drive 270 for storing user data in
addition to other software.
Figure 4 is a perspective view of a workstation 300 and a cartridge 302 that may
include one or more sors (not shown) as described herein. The workstation 300 may
include similar components as described above with respect to the bioassay system 100
and the workstation 200 and may operate in a r manner. For example, the
workstation 300 may include a workstation housing 304 and a system receptacle 306 that
is red to receive and engage the cartridge 302. The system receptacle may at least
one of fluidically or electrically engage the cartridge 302. The workstation housing 304
may hold, for example, a system controller, a fluid storage system, a fluidic control system,
and a temperature control system as described above. In Figure 4, the workstation 300
does not include a user interface or display that is coupled to the workstation g 304.
However, a user interface may be communicatively d to the housing 304 (and the
components/systems n) through a ication link. Thus, the user interface and
the workstation 300 may be remotely located with respect to each other. Together, the user
interface and the workstation 300 (or a plurality of workstations) may constitute a bioassay
system.
As shown, the cartridge 302 es a cartridge housing 308 having at least one
port 310 that provides access to an interior of the cartridge housing 308. For example, a
solution that is configured to be used in the cartridge 302 during the controlled reactions
may be inserted through the port 310 by a technician or by the workstation 300. The
system receptacle 306 and the cartridge 302 may be sized and shaped relative to each other
such that the cartridge 302 may be inserted into a receptacle caVity (not shown) of the
system receptacle 306.
Figure 5 is a front View of a rack assembly 312 haVing a cabinet or carriage 314
with a plurality of the workstations 300 loaded thereon. The cabinet 3 14 may include one
or more shelves 316 that define one or more reception spaces 3l8 configured to receive
one or more ations 300. Although not shown, the workstations 300 may be
communicatively d to a communication k that permits a user to control
operation of the workstations 300. In some embodiments, a bioassay system includes a
plurality of workstations, such as the workstations 300, and a single user interface
configured to l ion of the multiple workstations.
Figure 6 illustrates various features of the cartridge 302 (Figure 4) in accordance
with one embodiment. As shown, the dge 302 may include a sample assembly 320,
and the system receptacle 306 may include a light ly 322. Stage 346 shown in
Figure 6 represents the spatial relationship between the first and second sub-assemblies
320 and 322 when they are separate from each other. At stage 348, the first and second
sub-assemblies 320 and 322 are joined together. The cartridge g 308 (Figure 4) may
enclose the joined first and second semblies 320 and 322.
In the illustrated embodiment, the first sub-assembly 320 includes a base 326 and
a on-component body 324 that is mounted onto the base 326. Although not shown,
one or more biosensors may be mounted to the base 326 in a recess 328 that is defined, at
least in part, by the reaction-component body 324 and the base 326. For example, at least
four biosensors may be mounted to the base 326. In some embodiments, the base 326 is a
WO 89092
printed circuit board having circuitry that enables communication between the different
components of the dge and the workstation 300 (Figure 4). For example, the
reaction-component body 324 may include a rotary valve 330 and reagent oirs 332
that are fluidically coupled to the rotary valve 330. The reaction-component body 324 may
also include additional oirs 334.
The second sub-assembly 322 es a light assembly 336 that includes a
plurality of light directing channels 338. Each light directing channel 338 is optically
coupled to a light source (not shown), such as a light-emitting diode (LED). The light
source(s) are configured to provide an tion light that is directed by the light directing
channels 338 onto the biosensors. In alternative embodiments, the cartridge may not
include a light source(s). In such embodiments, the light source(s) may be located in the
workstation 300. When the cartridge is inserted into the system receptacle 306 (Figure 4),
the dge 302 may align with the light source(s) so that the biosensors may be
illuminated.
Also shown in Figure 6, the second sub-assembly 322 includes a cartridge pump
340 that is fluidically coupled to ports 342 and 344. When the first and second sub-
lies 320 and 322 are joined together, the port 342 is coupled to the rotary valve 330
and the port 344 is coupled to the other reservoirs 334. The cartridge pump 340 may be
activated to direct reaction components from the reservoirs 332 and/or 334 to the
biosensors according to a designated protocol.
Figure 7 illustrates a cross-section of a portion of an exemplary biosensor 400
formed in ance with one embodiment. The biosensor 400 may include similar
features as the biosensor 102 (Figure 1) described above and may be used in, for example,
the cartridge 302 (Figure 4). As shown, the biosensor 400 may include a flow cell 402 that
is coupled directly or indirectly to a ion device 404. The flow cell 402 may be
d to the detection device 404. In the illustrated embodiment, the flow cell 402 is
affixed ly to the detection device 404 through one or more securing mechanisms
(e.g., adhesive, bond, fasteners, and the like). In some embodiments, the flow cell 402
may be removably coupled to the detection device 404.
WO 89092
In the illustrated embodiment, the detection device 404 includes a device base
425. In particular embodiments, the device base 425 es a plurality of stacked layers
(e.g., silicon layer, dielectric layer, metal-dielectric layers, etc.). The device base 425 may
include a sensor array 424 of light s 440, a guide array 426 of light guides 462, and a
reaction array 428 of reaction recesses 408 that have corresponding reaction sites 414. In
certain embodiments, the components are arranged such that each light sensor 440 aligns
with a single light guide 462 and a single reaction site 414. However, in other
embodiments, a single light sensor 440 may receive photons through more than one light
guide 462 and/or from more than one reaction site 414. As used , a single light
sensor may include one pixel or more than one pixel.
Moreover, it is noted that the term “array” or “sub-array” does not necessarily
e each and every item of a certain type that the detection device may have. For
e, the sensor array 424 may not include each and every light sensor in the detection
device 404. Instead, the detection device 404 may include other light sensors (e.g., other
array(s) of light sensors). As another example, the guide array 426 may not include each
and every light guide of the detection device. Instead, there may be other light guides that
are configured differently than the light guides 462 or that have different relationships with
other elements of the detection device 404. As such, unless explicitly recited otherwise,
the term “array” may or may not include all such items of the ion .
In the illustrated embodiment, the flow cell 402 includes a sidewall 406 and a
flow cover 410 that is supported by the sidewall 406 and other sidewalls (not shown). The
sidewalls are coupled to the or surface 412 and extend between the flow cover 410
and the detector surface 412. In some embodiments, the sidewalls are formed from a
curable adhesive layer that bonds the flow cover 410 to the detection device 404.
The flow cell 402 is sized and shaped so that a flow channel 418 exists between
the flow cover 410 and the detection device 404. As shown, the flow channel 418 may
include a height H1. By way of example only, the height H1 may be between about 50-400
um (microns) or, more particularly, about 80-200 um. In the illustrated embodiment, the
height H1 is about 100 um. The flow cover 410 may include a material that is transparent
to excitation light 401 propagating from an exterior of the biosensor 400 into the flow
channel 418. As shown in Figure 7, the excitation light 401 approaches the flow cover 410
at a non-orthogonal angle. However, this is only for illustrative purposes as the excitation
light 401 may approach the flow cover 410 from different angles.
Also shown, the flow cover 410 may include inlet and outlet ports 420, 422 that
are configured to fluidically engage other ports (not shown). For example, the other ports
may be from the cartridge 302 (Figure 4) or the workstation 300 (Figure 4). The flow
channel 418 is sized and shaped to direct a fluid along the or surface 412. The height
H1 and other dimensions of the flow channel 418 may be configured to maintain a
substantially even flow of a fluid along the detector surface 412. The dimensions of the
flow channel 418 may also be configured to control bubble ion.
The sidewalls 406 and the flow cover 410 may be separate components that are
coupled to each other. In other embodiments, the sidewalls 406 and the flow cover 410
may be integrally formed such that the sidewalls 406 and the flow cover 410 are formed
from a continuous piece of material. By way of example, the flow cover 410 (or the flow
cell 402) may comprise a transparent material, such as glass or plastic. The flow cover 410
may tute a substantially gular block having a planar exterior surface and a
planar inner surface that defines the flow channel 418. The block may be mounted onto
the sidewalls 406. atively, the flow cell 402 may be etched to define the flow cover
410 and the sidewalls 406. For example, a recess may be etched into the transparent
material. When the etched material is mounted to the detection device 404, the recess may
become the flow channel 418.
The detection device 404 has a detector surface 412 that may be functionalized
(e.g., chemically or physically modified in a suitable manner for conducting designated
reactions). For e, the detector surface 412 may be filnctionalized and may include a
plurality of reaction sites 414 having one or more biomolecules immobilized o. The
detector surface 412 has an array of reaction recesses or open-sided reaction chambers 408.
Each of the on recesses 408 may include one or more of the reaction sites 414. The
on recesses 408 may be defined by, for example, an indent or change in depth along
the detector surface 412. In other embodiments, the detector surface 412 may be
substantially .
As shown in Figure 7, the reaction sites 414 may be distributed in a pattern along
the detector surface 412. For instance, the ons sites 414 may be located in rows and
columns along the detector surface 412 in a manner that is similar to a microarray.
However, it is tood that various patterns of reaction sites may be used. The reaction
sites may include biological or al substances that emit light signals. For example,
the biological or chemical substances of the reactions sites may generate light emissions in
response to the excitation light 401. In ular embodiments, the reaction sites 414
include clusters or colonies of biomolecules (e.g., oligonucleotides) that are immobilized
on the detector e 412.
Figure 8 is an enlarged cross-section of the detection device 404 showing various
es in greater detail. More specifically, Figure 8 shows a single light sensor 440, a
single light guide 462 for directing light emissions toward the light sensor 440, and
associated circuitry 446 for transmitting signals based on the light emissions (e.g., photons)
detected by the light sensor 440. It is understood that the other light sensors 440 of the
sensor array 424 (Figure 7) and associated components may be configured in an identical
or similar manner. It is also understood, however, the detection device 404 is not required
to be manufactured identically or uniformly throughout. Instead, one or more light sensors
440 and/or associated components may be ctured differently or have different
relationships with respect to one another.
The try 446 may include interconnected conductive elements (e.g.,
conductors, traces, vias, interconnects, etc.) that are capable of conducting electrical
current, such as the ission of data signals that are based on detected photons. For
example, in some embodiments, the circuitry 446 may be similar to or include a
microcircuit arrangement, such as the ircuit arrangement described in US. Patent
No. 7,595,883, which is orated herein by nce in the entirety. The detection
device 404 and/or the device base 425 may comprise an integrated circuit having a planar
array of the light sensors 440. The circuitry 446 formed within the detection device 425
PCT/U82014/069373
may be configured for at least one of signal amplification, digitization, storage, and
processing. The circuitry may t and analyze the detected light emissions and
generate data signals for communicating detection data to a ay system. The circuitry
446 may also perform onal analog and/or digital signal processing in the detection
device 404.
The device base 425 may be manufactured using ated circuit
manufacturing processes, such as processes used to manufacture complementary-metal-
oxide semiconductors (CMOSs). For example, the device base 425 may include a plurality
of stacked layers 431-437 including a sensor layer or base 431, which is a silicon layer or
wafer in the illustrated embodiment. The sensor layer 431 may e the light sensor
440 and gates 441-443 that are formed with the sensor layer 431. The gates 441-443 are
electrically coupled to the light sensor 440. When the detection device 404 is fully formed
as shown in Figures 7 and 8, the light sensor 440 may be electrically coupled to the
circuitry 446 through the gates 441-443.
As used herein, the term “layer” is not limited to a single continuous body of
al unless otherwise noted. For example, the sensor layer 431 may include multiple
sub-layers that are different als and/or may include coatings, adhesives, and the like.
Furthermore, one or more of the layers (or sub-layers) may be modified (e.g., etched,
deposited with material, etc.) to provide the features described herein.
In some embodiments, each light sensor 440 has a detection area that is less
than about 50 umz. In particular embodiments, the detection area is less than about 10
umz. In more particular embodiments, the detection area is about 2 umz. In such cases, the
light sensor 440 may constitute a single pixel. An average read noise of each pixel in a
light sensor 440 may be, for example, less than about 150 ons. In more particular
embodiments, the read noise may be less than about 5 electrons. The resolution of the
array of light s 440 may be greater than about 0.5 megapixels (Mpixels). In more
specific embodiments, the resolution may be greater than about 5 Mpixels and, more
particularly, greater than about 10 Mpixels.
W0 2015/089092
The device layers also include a plurality of metal-dielectric layers 432-437,
which are hereinafter referred to as substrate . In the illustrated embodiment, each of
the ate layers 432-437 includes metallic elements (e. g., W (tungsten), Cu r), or
Al (aluminum)) and dielectric material (e.g., SiOz). Various metallic elements and
dielectric material may be used, such as those suitable for integrated circuit manufacturing.
However, in other embodiments, one or more of the ate layers 432-437 may include
only dielectric material, such as one or more layers of SiOz.
With respect to the specific embodiment shown in Figure 8, the first substrate
layer 432 may include metallic elements referred to as Ml that are embedded within
dielectric material (e.g., SiOz). The ic elements Ml comprise, for example, W
(tungsten). The metallic elements Ml extend entirely through the substrate layer 432 in
the illustrated embodiment. The second ate layer 433 includes metallic elements M2
and tric material as well as a metallic interconnects (M2/M3). The third substrate
layer 434 includes metallic ts M3 and metal interconnects (M3/M4). The fourth
substrate layer 435 also includes ic elements M4. The device base 425 also includes
fifth and sixth substrate layers 436, 437, which are bed in greater detail below.
As shown, the metallic elements and interconnects are connected to each other
to form at least a n of the circuitry 446. In the illustrated embodiment, the metallic
elements Ml, M2, M3, M4 include W ten), Cu (copper), and/or aluminum (Al) and
the metal interconnects M2/M3 and M3/M4 include W (tungsten), but it is understood that
other als and configurations may be used. It is also noted that the device base 425
and the detection device 404 shown in Figures 7 and 8 are for illustrative purposes only.
For example, other embodiments may include fewer or additional layers than those shown
in Figures 7 and 8 and/or different configurations of metallic elements.
In some ments, the detection device 404 includes a shield layer 450 that
extends along an outer surface 464 of the device base 425. In the illustrated embodiment,
the shield layer 450 is deposited directly along the outer surface 464 of the substrate layer
437. However, an intervening layer may be disposed between the substrate layer 437 and
the shield layer 450 in other embodiments. The shield layer 450 may include a material
-3 6-
that is configured to block, reflect, and/or significantly attenuate the light signals that are
propagating from the flow l 418. The light signals may be the excitation light 401
and/or the light emissions 466 (shown in Figure 9). By way of example only, the shield
layer 450 may comprise tungsten (W).
As shown in Figure 8, the shield layer 450 includes an aperture or g 452
hrough. The shield layer 450 may include an array of such apertures 452. In some
embodiments, the shield layer 450 may extend continuously between adjacent res
452. As such, the light signals from the flow l 418 may be blocked, reflected,
and/or significantly attenuated to prevent detection of such light signals by the light
sensors 440. However, in other embodiments, the shield layer 450 does not extend
continuously n the adjacent apertures 452 such then one or more openings other
than the apertures 452 exits in the shield layer 450.
The detection device 404 may also include a ation layer 454 that extends
along the shield layer 450 and across the apertures 452. The shield layer 450 may extend
over the apertures 452 thereby ly or ctly covering the apertures 452. The shield
layer 450 may be located between the passivation layer 454 and the device base 425. An
adhesive or promoter layer 458 may be located therebetween to facilitate coupling the
passivation and shield layers 454, 450. The passivation layer 454 may be configured to
protect the device base 425 and the shield layer 450 from the fluidic environment of the
flow channel 418.
] In some cases, the ation layer 454 may also be configured to provide a
solid surface (i.e., the detector surface 412) that permits biomolecules or other analytes-of-
interest to be immobilized thereon. For example, each of the reaction sites 414 may
include a cluster of biomolecules that are immobilized to the detector surface 412 of the
passivation layer 454. Thus, the passivation layer 454 may be formed from a material that
permits the reaction sites 414 to be immobilized thereto. The passivation layer 454 may
also comprise a material that is at least transparent to a desired fluorescent light. By way
of example, the passivation layer 454 may include silicon nitride (Si3N4) and/or silica
(SiOz). However, other suitable material(s) may be used. In addition, the passivation layer
W0 2015/089092
454 may be physically or chemically modified to facilitate immobilizing the biomolecules
and/or to facilitate detection of the light emissions.
In the illustrated embodiment, a portion of the passivation layer 454 extends
along the shield layer 450 and a portion of the passivation layer 454 extends directly along
filter material 460 of a light guide 462. The reaction recess 408 may be formed directly
over the light guide 462. In some cases, prior to the passivation layer 454 being ted
along the shield layer 450 or adhesion layer 458, a base hole or cavity 456 may be formed
within the device base 425. For example, the device base 425 may be etched to form an
array of the base holes 456. In particular embodiments, the base hole 456 is an elongated
space that extends from proximate the aperture 452 toward the light sensor 440. The base
hole may extend lengthwise along a central longitudinal axis 468. A three-dimensional
shape of the base hole 456 may be substantially cylindrical or frustro-conical in some
embodiments such that a cross-section taken along a plane that extends into the page of
Figure 8 is substantially circular. The longitudinal axis 468 may extend through a
geometric center of the cross-section. However, other ries may be used in
ative embodiments. For example, the cross-section may be substantially square-
shaped or octagonal.
The filter al 460 may be deposited within the base hole 456 after the base
hole 456 is formed. The filter al 460 may form (e.g., after curing) a light guide 462.
The light guide 462 is configured to filter the tion light 401 and permit the light
emissions 466 to propagate therethrough toward the corresponding light sensor 440. The
light guide 462 may be, for example, an organic absorption filter. By way of specific
example only, the tion light may be about 532 nm and the light emissions may be
about 570 nm or more.
In some cases, the c filter material may be incompatible with other
materials of the sor. For example, organic filter material may have a ient of
thermal expansion that causes the filter material to significantly expand. Alternatively or
in addition to, the filter material may be unable to sufficiently adhere to certain layers, such
as the shield layer (or other metal layers). Expansion of the filter material may cause
mechanical stress on the layers that are nt to the filter material or structurally
connected to the filter al. In some cases, the expansion may cause cracks or other
unwanted features in the structure of the biosensor. As such, embodiments set forth herein
may limit the degree to which the filter material expands and/or the degree to which the
filter material is in contact with other . For example, the filter material of different
light guides may be ed from each other by the passivation layer. In such
embodiments, the filter material may not contact the metal layer(s). Moreover, the
passivation layer may resist expansion and/or permit some expansion while reducing
generation of ed structural es (e.g., cracks).
The light guide 462 may be configured relative to surrounding material of the
device base 425 (e.g., the dielectric material) to form a light-guiding structure. For
example, the light guide 462 may have a refractive index of about 2.0 so that the light
emissions are substantially ed at an interface between the light guide 462 and the
material of the device base 425. In certain embodiments, the light guide 462 is configured
such that the optical density (OD) or absorbance of the excitation light is at least about 4
OD. More specifically, the filter material may be selected and the light guide 462 may be
dimensioned to achieve at least 4 OD. In more particular embodiments, the light guide 462
may be configured to achieve at least about 5 OD or at least about 6 OD. Other features of
the biosensor 400 may be configured to reduce electrical and l alk.
Figure 9 illustrates an enlarged view of the detector surface 412 and portions of
the detection device 404 (Figure 7) that are located proximate to the detector surface 412.
More specifically, the passivation layer 454, the adhesion layer 458, the shield layer 450,
and the light guide 462 are shown in Figure 9. Each of the layers may have a outer (top)
surface or an inner (bottom) surface and may extend along an nt layer at an interface.
In some embodiments, the detector surface 412 is configured to form the reaction recess
408 proximate to the aperture 452. The reaction recess 408 may be, for example, an
indent, pit, well, groove, or open-sided chamber or channel. Alternatively, the detector
e 412 may be planar without the recesses shown in Figures 7-9. As shown, the
aperture 452 is defined by an aperture or layer edge 504. The layer edge 504 faces radially
inward toward the longitudinal axis 468.
The detector surface 412 may include an elevated portion 502 and the reaction
recess 408 may include a base surface 490. The base surface 490 may extend substantially
parallel to the shield layer 450. The detector surface 412 may also include a side surface
492 that extends substantially onal to the base surface 490 and the elevated portion
502 of the or surface 412. The side surface 492 may define a periphery of the
on recess 408. Although the elevated n 502, the base surface 490, and the side
surface 492 are referenced as separate surfaces it is understood that the surfaces may be
portions of the detector surface 412. Moreover, it is understood that, due to manufacturing
tolerances, the surfaces may not have be readily distinct. For example, in other
embodiments, the base e 490 and the side surface 492 may be substantially a single
surface with a e shape.
The base surface 490 may represent (or include a point that represents) a
deepest portion of the passivation layer 454 along the detector surface 412 within the
reaction recess 408. For example, the elevated n 502 may extend along a surface
plane P1 and the base surface 490 may extend along a e plane P2. As shown, the
e planes P1 and P2 are offset with respect to each other by a depth or distance D1.
The surface plane P2 is closer to the light guide 462 or the light sensor 440 (Figure 7) than
the surface plane P1. In the illustrated embodiment, the depth D1 of the base surface 490 is
substantially continuous due to the base surface 490 being substantially planar. In other
embodiment, however, the depth D1 may vary. For example, the base surface 490 may
have a concave shape with the depth increasing as the base surface 490 extends toward a
center or middle thereof.
The reaction recess 408 may extend toward or be located within the aperture
452. For instance, at least a portion of the base surface 490 may reside within the aperture
452. The shield layer 450 may have an outer surface 506 that faces the passivation layer
454 and an inner surface 508 that faces the device base 425. The outer e 506 may
extend along a surface plane P3, and the inner surface 508 may extend along a surface
PCT/USZOl4/069373
plane P4. The distance between the e planes P3 and P4 may represent a thickness of
the shield layer 450. As shown, the surface plane P3 may be located between the surface
planes P1, P2. As such, the base surface 490 extends within the aperture 452 as defined by
the layer edge 504. In other embodiments, however, the surface plane P2 may be located
above the surface plane P3 such that the base surface 490 does not reside within the
aperture 452. er, in some embodiments, the surface plane P2 may be located below
the surface plane P4 such that base surface 490 is located below the aperture 452.
The ation layer 454 includes the detector surface 412 and an inner surface
510 that extends along the outer surface 506 of the shield layer 450 at an ace 5 12. In
some embodiments, the adhesion layer 458 may extend along and define the interface 512
between the shield layer 450 and the passivation layer 454.
] In the illustrated embodiment, the passivation layer 454 extends ly along
the light guide 462. More specifically, the inner surface 510 of the passivation layer 454
may directly engage a al surface 514 of the light guide 462. As used herein, the
phrase “directly engage” and the like may include the two layers directly contacting each
other or the two layers being bonded to each other through the use of an adhesion promoter
material(s). The light guide 462 has an input region 472 that includes the material surface
514. The input region 472 may represent a portion of the light guide 462 that initially
es the light emissions.
The inner surface 510 may directly engage the al surface 514 at an
interface 516. The interface 516 may represent a material level of the filter material 460
that is deposited within the guide cavity 456 (Figure 7). In the illustrated embodiment, the
interface 516 is substantially planar such that the interface 516 extends along an interface
plane P5. The interface plane P5 may extend substantially parallel to one or more of the
surface planes P1, P2, P3, P4. In other embodiments, however, the interface 516 may have a
concave shape such that the interface 516 bows toward the light sensor 440 (Figure 8) or in
an opposite direction away from the light sensor 440.
The passivation layer 454 may fill a void generated when the re 452 is
formed. Thus, in some embodiments, the passivation layer 454 may be located within or
PCT/USZOl4/069373
reside in the aperture 452. In particular embodiments, the interface 516 may be located a
depth D2 into the device base 425. In particular embodiments, the depth D2 may be
configured such that the interface 516 is located below the aperture 452 as shown in Figure
8. In such embodiments, the ation layer 454 may isolate (e.g., separate) the filter
material 460 and the shield layer 450. Such embodiments may be suitable when the filter
material 460 and the shield layer 450 are incompatible such that cracks or other unwanted
features may develop during manufacture of usage of the biosensor 400 (Figure 7). In
other embodiments, at least a portion of the interface 516 may be located within the
aperture 452.
Also shown in Figure 9, the ation layer 454 may form a joint or comer
region 519. The joint region 519 may e the side e 492 and extend around the
longitudinal axis 468. The joint region 519 may include a relatively thicker portion of the
passivation layer 454 that extends from the elevated portion 502 to the inner surface 510 at
the material interface 516 (or between the surface plane P1 and the interface plane P5). The
dimensions of the joint region 519 may resist mechanical es caused by expansion of
the filter material 460 during manufacture of the biosensor 400 and/or during thermal
cycling that may occur during designated protocols (e.g., SBS sequencing). As shown, the
thickness between the e plane P1 and the interface plane P5 is more than twice the
thickness between the elevated portion 502 of the detector surface 412 and the interface
512.
The reaction site 414 may include biological or chemical substances, which are
lly represented as dots 520 in Figure 9. The biological or chemical nces may
be immobilized to the detector surface 412 or, more specifically, the base and side es
490, 492. In particular embodiments, the reaction site 414 is located proximate to the
aperture 452 so that light emissions propagate h the passivation layer 454, through
the aperture 452, and into the input region 472 of the light guide 462.
In some embodiments, the reaction sites 414 or the biological or chemical
substances 520 therein may be patterned such that the reaction sites 414 or substances 520
have predetermined locations. For example, after the passivation layer 454 is applied, the
PCT/USZOl4/069373
reaction sites 414 or ns thereof may be ned onto the passivation layer 454. In
the illustrate embodiment, each aperture 452 is associated with a single reaction site 414
such that the light emissions from the reaction site 414 are directed toward the
corresponding light sensor 440. The biological or chemical substances 520 in a single
reaction site 414 may be similar or identical (e.g., a colony of oligonucleotides that have a
common ce). However, in other embodiments, more than one reaction site 414 may
pond to one of the apertures 452.
In particular embodiments, the reaction sites 414 may e pads or metal
regions that are described in US. Provisional Application No. 61/495,266, filed on June 9,
2011, and US. Provisional Application No. 61/552,712, filed on October 28, 2011. Each
of the US. Provisional Application No. 61/495,266 (the ‘266 Application) and the US.
Provisional Application No. 61/552,712 (the ‘712 Application) is incorporated herein by
reference in its entirety. In some embodiments, the on sites 414 may be fabricated
after the flow cell 402 (Figure 7) is manufactured on the detection device 404.
In the illustrated embodiment, the reaction site 414 includes a colony of
oligonucleotides 520 in which the oligonucleotides have an effectively common ce.
In such embodiments, each of the ucleotides may generate common light emissions
when the excitation light 401 is absorbed by the fluorophors incorporated within the
oligonucleotides. As shown, the light emissions 466 may emit in all directions (e.g.,
isotropically) such that, for example, a portion of the light is directed into the light guide
462, a portion of the light is directed to reflect off the shield layer 450, and a portion of the
light is directed into the flow channel 418 or the passivation layer 454. For the portion that
is directed into the light guide 462, embodiments described herein may be configured to
facilitate detection of the photons.
Also shown in Figure 9, the device base 425 may include peripheral crosstalk
shields 522, 524 located within the device base 425. The crosstalk shields 522, 524 may
be positioned relative to the light guide 462 and configured so that the crosstalk shields
522, 524 block or reflect light signals propagating out of the light guide 462. The light
s may include the tion light 401 that has been reflected or refracted and/or the
2014/069373
light emissions 466 generated at or proximate to the detector surface 412. In some
embodiments, the alk shields 522, 524 may also directly block the excitation light
401 from the flow channel 418. As such, the crosstalk shields 522, 524 may reduce
detection of unwanted light signals. For example, the alk shields 522, 524 may
reduce optical crosstalk n adjacent light sensors 440 and/or may improve collection
efficiency of the corresponding light sensor 440. The crosstalk shields 522, 524 may be,
for example, metallic elements that are ated during the cture of the device
base 425. In some embodiments, the processes used to fabricate the M1, M2, M3, M2/M3,
and M3/M4 elements of the circuitry 446 (Figure 8) may be the same as or similar to the
processes that fabricate the crosstalk shields 522, 524. For example, the crosstalk s
522, 524 may be located within dielectric material (e.g., dielectric layers) of the device
base 425 and comprise the same material that is used to ate the circuitry 446 (e.g.,
one or more of the als used to ate the M1, M2, M3, M2/M3, and M3/M4
ts). Although not shown, in some cases, the different stages of CMOS manufacture
may include forming the ic elements that will transmit data signals while also
forming the crosstalk shields.
Although the crosstalk shields 522, 524 may be manufactured in a similar
manner as the circuitry 446, the crosstalk shields 522, 524 may be electrically separate
from the circuitry 446. In other words, for some embodiments, the crosstalk shields 522,
524 may not transmit data signals. In other embodiments, however, the crosstalk shields
522, 524 may be traces or other metallic elements that are configured to transmit data
signals. As also shown in Figure 9, the crosstalk shields 522, 524 may have different
cross-sectional dimensions (e.g., width, height or ess) and shapes and may also be
fabricated from different materials.
In the illustrated embodiment, the crosstalk shields 522, 524 are coupled to each
other to form a single larger crosstalk shield. However, the crosstalk shields 522, 524 may
be spaced apart from each other in other configurations. For example, the crosstalk shields
522, 524 may be spaced apart from each other along the longitudinal axis 468. In the
illustrated embodiment, the crosstalk shields 522, 524 at least partially surround the input
PCT/USZOl4/069373
region 472 and a portion of the passivation layer 454. The crosstalk shield 522 directly
engages the shield layer 450. In some embodiments, the crosstalk shields 522, 524 may
only partially surround the light guide 462. In other embodiments, the crosstalk shields
522, 524 may constitute crosstalk rings that ferentially nd the entire light
guide 462. Such embodiments are described in greater detail below with respect to Figures
and 11.
As shown, the guide cavity 456 is defined by one or more interior surfaces 526
of the device base 425. In ular embodiments, the or surfaces 526 may be
surface(s) of the dielectric material (e.g., SiOz) from the substrate layers 432-437. The
crosstalk shields 522, 524 may directly abut the light guide such that a portion of the
metallic elements is exposed to and ly engages the filter material 460 of the light
guide 462. In other embodiments, however, the crosstalk shields 522, 524 are not exposed
to the light guide 462 and, instead, may be oned ately adjacent to the light
guide 462 such that a portion of the dielectric material is located between the crosstalk
shields 522, 524 and the light guide 462. For example, in the illustrated embodiment,
dielectric material 528, 530 is located between the light guide 462 and the crosstalk shields
522, 524, respectively. The dielectric material 528, 530 may each include a portion of the
interior surface 526. The dielectric material 528, 530 may separate the light guide 462
from the respective crosstalk shields 522, 524 by a separation distance SD. By way of
example only, the separation distance SD may be at least about 150 nm. In some
embodiments, the separation distance SD is at least about 100 nm. The tion ce
SD may be less than 100 nm.
Figure 10 is a tic cross-section of a detection device 602 formed in
accordance with another embodiment. The detection device 602 may include similar
features as the detection device 404 (Figure 7) and may be used in sors, such as the
biosensor 400 (Figure 7) or the biosensor 102 (Figure l). The detection device 602 may
also be ctured using integrated circuit manufacturing technologies. The detection
device 602 is described and illustrated to demonstrate other features that detection devices
and biosensors may have. In some embodiments, the detection device 602 alone may
W0 2015/089092 2014/069373
constitute a biosensor. In other embodiments, the detection device 602 may be coupled to
a flow cell to form a biosensor. For example, the ion device 602 may be coupled to
the flow cell 402 and form a flow channel n the detection device 602 and the flow
cell 402.
As shown, the detection device 602 includes a device base 604, a shield layer
640, and multiple sub-layers 652, 654 that collectively form a passivation layer 650 of the
detection device 602. The device base 604 includes a sensor array 606 of light sensors 608
and a guide array 610 of light guides 612. The light sensors 608 may be similar or
identical to the light sensors 440, and the light guides 612 may be similar or identical to the
light guides 462. For example, the light guides 612 are configured to receive the excitation
light 614 and the light emissions 616. As shown, the light emissions 616 are illustrated as
light being emitted from a single point. It is understood that the light emissions may be
generated from multiple points along the passivation layer 650. Each of the light guides
612 extends into the device base 604 along a central longitudinal axis 618 from an input
region 620 of the light guide 612 toward a corresponding light sensor 608 of the sensor
array 606.
Similar to the light guides 462, the light guides 612 may include a filter al
that is configured to filter the tion light 614 and permit the light emissions 616 to
propagate therethrough toward the corresponding light sensors 608. The device base 604
includes device circuitry (not shown) that is electrically coupled to the light sensors 608
and configured to transmit data signals based on photons detected by the light s.
Although not shown in Figures 10 and 11, the circuitry of the device base 604 may be
located between the light guides 612 similar to the circuitry 446 (Figure 8) located n
the light guides 462.
As shown, the device base 604 es peripheral crosstalk shields 631-634
that are located within the device base 604. More specifically, each of the light guides 612
is surrounded by multiple crosstalk s 631-634. The crosstalk shields 631-634 for
each of the light guides 612 may be spaced apart from each other along the respective
longitudinal axis 618 such that gaps 641-643 are formed therebetween. The sizes of the
gaps 641-643 may be substantially equal to one another or may . For example, the
gaps 643 are slightly larger than the gaps 642.
In the illustrated embodiment, the crosstalk shields 631-634 are configured to
circumferentially surround the light guides 612. As used herein, the phrase
“circumferentially surround” is not intended to require that the light guides 612 have
circular cross-section and/or the crosstalk shields 631-634 have circular . Instead, a
crosstalk shield may circumferentially surround the light guide 612 if the crosstalk shield
surrounds the corresponding udinal axis 618. The crosstalk shield may completely
surround the longitudinal axis 618 or only partially nd the udinal axis 618. For
example, the crosstalk shields 4 may continuously extend around the corresponding
light guide 612 or, in other cases, the crosstalk shields 631-634 may include le sub-
elements that are individually distributed around the light guide 612 to at least partially
surround the corresponding light guide.
Similar to the shield layer 452, the shield layer 640 may form apertures 642
therethrough. The apertures 642 are ntially aligned with corresponding light guides
612 and light sensors 608 to permit light signals to propagate into the corresponding input
regions 620. The sub-layer 654 may be ted over the shield layer 640 such that the
material of the sub-layer 654 fills at least a portion of the apertures. In some embodiments,
an additional sub-layer 652 is deposited over the sub-layer 654 to form the passivation
layer 650. By way of example only, either of the sub-layers 652, 654 may include plasma
vapor deposition (PVD) TazOs or plasma-enhanced al vapor deposition (PECVD)
SixNy. In another embodiment, an additional sub-layer may be stacked onto the sub-layers
652, 654. By way of one specific example, the sub-layer 654 may be PVD Ta205, the sub-
layer 652 may be PECVD SiXNy, and an additional layer that is stacked onto the sub-layer
652 may be PVD TazOs.
Figure 11 is a flowchart illustrating a method 700 of manufacturing a biosensor
in accordance with one embodiment. The method 700 is illustrated in Figures 12A and
12B. The method 700, for example, may employ structures or aspects of various
embodiments (e.g., systems and/or methods) discussed herein. In various embodiments,
W0 2015/089092
certain steps may be omitted or added, certain steps may be combined, certain steps may
be performed aneously, certain steps may be performed concurrently, certain steps
may be split into multiple steps, certain steps may be performed in a different order, or
certain steps or series of steps may be re-performed in an iterative fashion.
The method 700 may e providing (at 702) a device base 800 having a
sensor array of light sensors 802. As shown, the device base 800 has an outer or external
surface 801. The device base 800 may be manufactured using integrated circuit
manufacturing technologies, such as CMOS cturing technologies. For example, the
device base 800 may include several substrate layers with different modified features (e.g.,
metallic elements) embedded therein. In some embodiments, the device base 800 may
include guide regions 804 and circuitry regions 806. The guide regions 804 may
correspond to portions of the device base 800 that will include, after the method 700, the
light guides. Adjacent guide regions 804 may be separated by the circuitry s 806
that include device circuitry (not shown), which may be similar to the device circuitry
described herein. More specifically, the device try may be electrically coupled to the
light sensors 802 and configured to transmit data signals based on s detected by the
light sensors 802. In some embodiments, the guide s 804 may include eral
crosstalk shields 808 that surround substrate material in the guide regions 804.
The method 700 may also include applying (at 704) a shield layer 810 to the
outer surface 801 of the device base 800 and forming (at 706) apertures 812 through the
shield layer 810. As described above, the shield layer 810 may include a metal material
that is configured to block light signals. The apertures 812 may be formed by applying a
mask (not shown) and removing material (e.g., h etching) of the shield layer 810 to
form the apertures 812.
At 708, guide cavities 814 may be formed in the device base 800. More
specifically, the substrate al within the guide regions 804 may be removed so that
the guide cavities 814 extend from proximate to the apertures 812 toward corresponding
light s 802. As shown in Figure 12A, interior surfaces 815 of the substrate material
may define the guide cavities 814. The guide cavities 814 may be sized and shaped such
that the interior surfaces 815 are proximate to the crosstalk shields 808. As described
herein, the crosstalk shields 808 may be immediately adjacent to the interior surfaces 815
or may be exposed in the guide cavities 814.
The method 700 may also include depositing (at 710) filter material 820 within
the guide cavities 814. The filter al 820 may be, for example, an c filter
material. In some embodiments, a portion of the filter al 820 may extend along the
shield layer 810 after the depositing operation. For example, the amount of the filter
material 820 applied to the device base 800 may exceed the available volume within the
guide cavities 814. As such, the filter material 820 may overflow the guide cavities 814
and extend along the shield layer 810.
In some embodiments, depositing (at 710) the filter material 820 may include
ng (e.g., using a squeegee-like component) the filter material 820 into the guide
es 814. Figure 12A appears to indicate a uniform layer of the filter al 820
along the shield layer 810. In some embodiments, the layer of filter material 820 may not
be uniform. For instance, only portions of the shield layer 810 may have the filter material
820 thereon. In alternative embodiments, the depositing operation may include selectively
filling each of the guide cavities 814 such that the filter material 820 does not clear or
overflow the guide cavities 814.
At 712, the filter material 820 may be cured. Optionally, the method 700 may
also include removing (at 714) the filter material 820 from the shield layer 810 and, in
some cases, ns of the filter al 820 from the guide cavities 814. The filter
material 820 may be removed from within the guide cavities 814 so that a material level
830 of the filter material 820 is located within the aperture 812 or at a depth below the
shield layer 810. In embodiments where the material level 830 is below the shield layer
810, the filter material 820 may not contact any material of the shield layer 810. The filter
material 820 within the guide cavities 814 may form light guides. Different processes may
be implemented for removing the filter al 820 from the shield layer 810. For
e, the removing operation may include at least one of etching the filter material or
chemically polishing the filter material.
As shown in Figure 12B, the method 700 may also include applying (at 716) a
passivation layer 832 to the shield layer 810 and to the filter al 820 of the light
guides such that the passivation layer 832 extends directly along the shield layer 810 and
across the apertures 812. The passivation layer 832 may extend ly along the light
guides at corresponding material interfaces 834, such as the material interfaces 516 (Figure
9). In the illustrated ment, the passivation layer 832 has a planar detector surface
836. In other embodiments, the detector surface 836 may form an array of reaction
recesses, such as the reaction recesses 408 (Figure 7). The reaction recesses may extend
toward or be located within corresponding apertures 812.
In some embodiments, the passivation layer 832 es multiple sub-layers
841-843. In particular embodiments, at least one of the sub-layers 841-843 includes
tantalum. For example, the sub-layer 841 may include tantalum pentoxide (TazOs), the
sub-layer 842 may include a low-temperature film (e.g., silicon e (SiXNy)), and the
sub-layer 843, which may have the detector surface 836, may include tantalum pentoxide
(TazOs). However, the sub-layers 841-843 are only provided as examples and other
passivation layers may include fewer sub-layers, more sub-layers, or sub-layers with
different materials. In some cases, only a single sub-layer is used for the passivation layer.
Optionally, the method 700 may include providing (at 718) reaction sites 850
and mounting a flow cell (not shown). Providing the reaction sites 850 may occur prior to
or after the flow cell is coupled to the detection . The on sites 850 may be
located at designation addresses such that the reaction sites 850 have a ermined
pattern along the detector e 836. The reaction sites may pond (e. g., one site to
one light sensor, one site to multiple light sensors, or multiple sites to one light ) in a
predetermined manner. In other embodiments, the reaction sites may be randomly formed
along the detector surface 836. As described herein, the reaction sites 850 may include
biological or chemical substances lized to the detector surface 836. The biological
or chemical substances may be configured to emit light signals in response to excitation
light. In particular embodiments, the reaction sites 850 include clusters or colonies of
ecules (e.g., oligonucleotides) that are immobilized on the detector surface 836.
W0 2015/089092
In an embodiment, a biosensor is provided that includes a flow cell and a
detection device having the flow cell coupled o. The flow cell and the detection
device form a flow channel that is configured to have biological or chemical substances
n that generate light emissions in response to an excitation light. The detection
device es a device base having a sensor array of light sensors and a guide array of
light guides. The light guides have input s that are configured to receive the
excitation light and the light emissions from the flow l. The light guides extend into
the device base from the input regions toward corresponding light s and have a filter
material that is configured to filter the excitation light and permit the light emissions to
propagate toward the corresponding light s. The device base includes device
circuitry electrically coupled to the light sensors and configured to transmit data signals
based on s detected by the light sensors. The detection device also includes a shield
layer that extends between the flow channel and the device base. The shield layer has
apertures that are positioned relative to the input regions of corresponding light guides
such that the light emissions propagate through the apertures into the corresponding input
regions. The shield layer extends between adjacent apertures and is configured to block
the excitation light and the light emissions incident on the shield layer between the
nt apertures.
In one aspect, the input regions of the light guides may be located within the
corresponding apertures of the shield layer or may be located a depth into the device base.
] In another aspect, the detection device may include a passivation layer that
extends along the shield layer such that the shield layer is n the passivation layer
and the device base. The passivation layer may extend across the apertures.
In particular cases, the filter material of the light guides may be an organic filter
material. The passivation layer may extend directly along the input regions of the light
guides and isolate the organic filter material from the shield layer. The material interfaces
may be located within the corresponding apertures of the shield layer or located a depth
into the device base. In certain embodiments, the passivation layer extends into the
W0 2015/089092 PCT/U82014/069373
apertures and forms an array of reaction recesses. The reaction recesses may extend
toward or be located within corresponding apertures.
] In certain embodiments, the biological or chemical substances are configured to
be d within the reaction recesses. In certain embodiments, the reaction recesses have
corresponding base surfaces. The base surfaces may be located within the aperture or
located a depth into the device base.
In r aspect, the device base includes peripheral crosstalk shields. Each of
the crosstalk shields may surround one of the corresponding light guides. The crosstalk
shields may be configured to reduce optical crosstalk between adjacent light sensors.
In another , the biosensor is lens-free such that the biosensor does not
include an optical t that focuses the light emissions toward a focal point.
] In an embodiment, a biosensor is provided that includes a flow cell and a
detection device having the flow cell coupled thereto. The flow cell and the detection
device form a flow channel that is red to have biological or chemical nces
therein that generate light emissions in se to an excitation light. The detection
device may include a device base having a sensor array of light sensors and a guide array
of light . The light guides are configured to receive the excitation light and the light
emissions fiom the flow channel. Each of the light guides extends into the device base
along a central longitudinal axis from an input region of the light guide toward a
corresponding light sensor of the sensor array. The light guides include a filter material
that is configured to filter the excitation light and permit the light emissions to propagate
therethrough toward the corresponding light sensors. The device base includes device
circuitry that is electrically coupled to the light sensors and red to transmit data
signals based on photons detected by the light sensors. The device base includes
peripheral crosstalk shields located therein that surround corresponding light guides of the
guide array. The crosstalk shields at least partially surround the corresponding light guides
about the respective longitudinal axis to reduce l crosstalk between adjacent light
SGHSOI‘S .
W0 2015/089092
In one aspect, the crosstalk shields may surround the input regions of the
corresponding light guides.
In another aspect, the crosstalk shields may include alk rings that
circumferentially surround the corresponding light guide.
] In another aspect, the deVice base may include a mentary-metal-oxide
semiconductor (CMOS) and the deVice circuitry. The crosstalk shields may include
metallic elements located within dielectric layers of the deVice base. The crosstalk shields
may be electrically separate from the deVice circuitry.
In another , a shield layer may extend between the flow channel and the
deVice base. The shield layer may have apertures that are positioned relative to the input
regions of corresponding light guides of the guide array. The apertures may permit the
light emissions to propagate therethrough into the input regions. The shield layer may
extend between adjacent apertures and is red to block the excitation light and the
light emissions incident on the shield layer between the adjacent apertures. For instance,
the input s of the light guides may be located within the corresponding apertures of
the shield layer or are located a depth into the deVice base.
In another aspect, the detection deVice may also include a passivation layer that
extends along the shield layer such that the shield layer is n the passivation layer
and the deVice base and across the apertures.
In another aspect, the crosstalk shield abuts or is immediately nt to the
shield layer.
In another aspect, the crosstalk s are first alk shields, and the deVice
base includes second crosstalk shields in which each of the light guides of the guide array
is at least partially surrounded by corresponding first and second crosstalk shields. For
e, the first and second crosstalk shields may be spaced apart from each other along
the corresponding longitudinal axis. In another embodiment, the first and second crosstalk
shields have different dimensions.
W0 2015/089092 PCT/U82014/069373
In an ment, a method of manufacturing a biosensor is ed. The
method includes providing a device base having a sensor array of light sensors and device
circuitry that is electrically coupled to the light sensors and configured to it data
signals based on photons detected by the light sensors. The device base has an outer
surface. The method also includes applying a shield layer to the outer surface of the device
base and forming apertures through the shield layer. The method also includes forming
guide cavities that extend from ponding apertures toward a ponding light
sensor of the sensor array and depositing filter material within the guide cavities. A
portion of the filter material extends along the shield layer. The method also includes
curing the filter material and removing the filter material from the shield layer. The filter
material within the guide cavities forms light guides. The method also includes applying a
passivation layer to the shield layer such that the passivation layer extends directly along
the shield layer and across the apertures.
In one aspect, removing the filter material from the shield layer includes
removing a portion of the filter material within the guide cavities such that a material level
of the filter material is located within the aperture or at a depth below the shield layer.
In another aspect, the passivation layer extends directly along the light guides at
ponding material interfaces. The material interfaces are d within the
corresponding apertures or located a depth into the device base.
In another aspect, the filter material is an organic filter material. The
passivation layer extends directly along the light guides and isolates the organic filter
material from the shield layer.
] In another aspect, the passivation layer forms an array of on es. The
reaction recesses extend toward or are located within corresponding apertures. For
instance, the reaction recesses may have corresponding base surfaces. The base surfaces
may be located within the aperture or d a depth into the device base.
In another aspect, the method includes coupling a flow cell to the device base to
form a flow channel between the passivation layer and the flow cell.
W0 89092
In another aspect, removing the filter material from the shield layer includes at
least one of etching the filter al or chemically polishing the filter material.
In another aspect, the passivation layer includes tantalum ide (T3205).
For example, the passivation layer may include multiple sub-layers in which at least one of
the yers includes tantalum pentoxide (TazOs). In a more c embodiment, the
sub-layers may include two tantalum pentoxide layers with a low-temperature film
therebetween.
] In another aspect, the device base has guide regions that include substrate
material prior to forming the guide cavities in which adjacent guide regions are separated
by circuitry regions that include the device circuitry. Forming the guide cavities may
include removing the substrate material of the guide regions.
In another aspect, the device base may include peripheral crosstalk shields that
surround the guide regions prior to forming the guide cavities. The alk shields may
at least partially surround the corresponding light guides after the light guides are formed.
The crosstalk shields may be configured to reduce optical crosstalk between adjacent light
SGHSOI‘S .
In an embodiment, a biosensor is provided that includes a device base having a
sensor array of light s and a guide array of light . The device base has an
outer surface. The light guides have input regions that are configured to receive excitation
light and light ons generated by biological or al substances proximate to the
outer surface. The light guides extend into the device base from the input regions toward
corresponding light sensors and have a filter material that is configured to filter the
excitation light and permit the light emissions to propagate toward the corresponding light
sensors. The device base includes device circuitry electrically coupled to the light sensors
and configured to transmit data signals based on photons detected by the light sensors.
The biosensor also includes a shield layer that extends along the outer surface of the device
base. The shield layer has apertures that are positioned relative to the input regions of
corresponding light guides such that the light emissions propagate h the apertures
into the ponding input regions. The shield layer extends between adjacent apertures
and is configured to block the excitation light and the light emissions incident on the shield
layer between the adjacent apertures.
In an embodiment, a sor is provided that includes a device base having a
sensor array of light sensors and a guide array of light guides. The device base has an
outer surface. The light guides are red to receive excitation light and light
emissions generated by biological or chemical substances proximate to the outer e.
Each of the light guides extends into the device base along a central longitudinal axis from
an input region of the light guide toward a corresponding light sensor of the sensor array.
The light guide includes a filter material that is configured to filter the excitation light and
permit the light emissions to propagate hrough toward corresponding light sensors.
The device base includes device circuitry that is electrically coupled to the light sensors
and are red to transmit data signals based on photons detected by the light sensors.
The device base includes peripheral alk shields located therein that nd
corresponding light guides of the guide array. The crosstalk shields at least partially
surrounding the corresponding light guides about the respective longitudinal axis to at least
one of block or reflect errant light rays to reduce optical crosstalk between adjacent light
SGHSOI‘S .
It is to be understood that the subject matter described herein is not limited in its
application to the details of construction and the arrangement of components set forth in
the description herein or illustrated in the gs hereof. The subject matter described
herein is capable of other embodiments and of being practiced or of being carried out in
various ways. Also, it is to be understood that the phraseology and terminology used
herein is for the purpose of ption and should not be regarded as limiting. The use of
“including, 3, “comprising,”
or “having” and variations thereof herein is meant to
encompass the items listed thereafter and equivalents f as well as additional items.
Unless ed or limited ise, the terms “mounted,” “connected,”
“supported,” and “coupled” and variations thereof are used broadly and encompass both
direct and indirect mountings, connections, supports, and couplings. Further, “connected”
and “coupled” are not restricted to physical or mechanical connections or couplings. Also,
W0 2015/089092
it is to be understood that phraseology and terminology used herein with reference to
device or element orientation (such as, for example, terms like ,” “below,” “front,”
“rear,” “distal,” mal,” and the like) are only used to fy ption of one or
more embodiments described herein, and do not alone indicate or imply that the deVice or
element referred to must have a particular orientation. In addition, terms such as “outer”
and “inner” are used herein for purposes of description and are not intended to indicate or
imply relative importance or significance.
It is to be understood that the above description is intended to be illustrative,
and not restrictive. For e, the above-described embodiments (and/or aspects
thereof) may be used in combination with each other. In addition, many modifications
may be made to adapt a particular situation or material to the teachings of the presently
described subject matter without departing from its scope. While the dimensions, types of
materials and coatings described herein are intended to define the parameters of the
disclosed subject matter, they are by no means limiting and are exemplary embodiments.
Many other embodiments will be apparent to those of skill in the art upon reViewing the
above description. The scope of the inventive subject matter should, therefore, be
determined with reference to the appended claims, along with the filll scope of lents
to which such claims are entitled. In the ed claims, the terms “including” and “in
which” are used as the plain-English equivalents of the respective terms “comprising” and
“wherein.” er, in the following claims, the terms “first,3, d,” and “third,” etc.
are used merely as labels, and are not intended to impose numerical requirements on their
objects. Further, the limitations of the following claims are not written in means — plus-
function format and are not intended to be interpreted based on 35 U.S.C. § 112, sixth
paragraph, unless and until such claim limitations expressly use the phrase “means for”
followed by a ent of fianction void of further structure.
] The following claims recite s of certain embodiments of the inventive
subject matter and are considered to be part of the above disclosure. These aspects may be
ed with one another.
Claims (22)
1. A device comprising: a flow cell; and a detection device having the flow cell coupled thereto, the flow cell and the detection device forming a flow channel that is ured to have substances n, the detection device including: a device base having a sensor array of light sensors and a guide array of light guides, the device base having an outer surface, the light guides ured to receive excitation light and light emissions from the substances in the flow channel, the light guides extending into the device base along a central longitudinal axis from an input region of the light guide toward a corresponding light sensor of the sensor array, the light guides including a filter al that is configured to filter the excitation light and permit the light emissions to ate hrough toward the corresponding light sensors, the device base including device circuitry that is electrically coupled to the light sensors and ured to transmit data signals based on photons detected by the light sensors; a passivation layer that extends over the outer surface of the device base and forms an array of reaction recesses above the light guides; wherein the device base includes peripheral alk shields located therein that at least partially surround corresponding light guides of the guide array, the crosstalk shields at least partially surrounding the corresponding light guides about the respective longitudinal axis to reduce optical crosstalk between adjacent light sensors.
2. The device of claim 1, wherein the crosstalk shields surround the input regions of the corresponding light guides.
3. The device of claim 1, wherein the crosstalk shields include crosstalk rings that circumferentially surround the corresponding light guide.
4. The device of claim 1, wherein the device base includes a complementarymetal-oxide semiconductor (CMOS) and the crosstalk shields include metallic elements located within dielectric layers of the device base, the crosstalk shields being electrically separate from the device circuitry.
5. The device of claim 1, wherein the reaction recesses have corresponding base surfaces, the base surfaces being located above the light guides at a depth into the device base.
6. The device of claim 1, further comprising a shield layer extending between the passivation layer and the device base, the shield layer having apertures that are positioned relative to the input regions of corresponding light guides of the guide array, the apertures ting the light emissions to ate therethrough into the input regions, the shield layer ing n nt apertures and configured to block the excitation light and the light emissions incident on the shield layer between the adjacent apertures.
7. The device of claim 6, wherein the input regions of the light guides are located within the corresponding apertures of the shield layer or are located a depth into the device base.
8. The device of claim 6, wherein the passivation layer extends along the shield layer such that the shield layer is between the ation layer and the device base, the passivation layer ing across the apertures.
9. The device of claim 8, n the passivation layer includes tantalum pentoxide (Ta2O5).
10. The device of claim 8, wherein the passivation layer includes multiple sublayers in which at least one of the sub-layers includes tantalum pentoxide (Ta2O5).
11. The device of claim 10, wherein the yers includes two tantalum pentoxide (Ta2O5) layers with a low-temperature film therebetween.
12. The device of claim 10, wherein the sub-layers include two plasma vapor deposition (PVD) tantalum pentoxide layers with a plasma enhanced chemical vapor deposition (PECVD) silicon e film therebetween.
13. The device of claim 6, wherein the crosstalk shields abut or are immediately adjacent to the shield layer.
14. The device of claim 6, wherein the shield layer is in t with the passivation layer, but is not in contact with the filter material of the light guides.
15. The device of claim 1, wherein the crosstalk shields are first crosstalk shields, the device base including second crosstalk shields, wherein each of the light guides of the guide array is at least partially surrounded by corresponding first and second crosstalk shields.
16. The device of claim 15, wherein the first and second crosstalk shields are spaced apart from each other along the corresponding longitudinal axis.
17. The device of claim 15, wherein the first and second crosstalk shields have different dimensions.
18. A device comprising: a device base having a sensor array of light sensors and a guide array of light , the device base having an outer e, the light guides having input s that are configured to receive excitation light and light emissions ted by substances proximate to the outer surface, the light guides extending into the device base from the input regions toward corresponding light sensors and having a filter material that is configured to filter the excitation light and permit the light emissions to propagate toward the corresponding light sensors; wherein the device base es peripheral crosstalk shields located therein that at least partially surround corresponding light guides of the guide array, the crosstalk shields at least partially surrounding the corresponding light guides about the respective longitudinal axis to at least one of block or reflect errant light rays to reduce optical alk between adjacent light sensors.
19. The device of claim 18, further comprising a passivation layer that extends over the outer surface of the device base and forms an array of reaction recesses above the light guides.
20. The device of claim 19, wherein the reaction recesses have ponding base surfaces, the base surfaces being located above the light guide at a depth into the device base.
21. A method of manufacturing a device, the method comprising: forming guide cavities in a device base, the device base having a sensor array of light sensors and device circuitry that is electrically coupled to the light sensors and to transmit data signals based on photons detected by the light sensors, the device base having an outer surface and peripheral crosstalk s extending from the outer surface toward the light sensors; n the guide cavities extend from corresponding res toward a corresponding light sensor of the sensor array, such that the guide cavities are separated by the peripheral crosstalk shields; depositing filter al within the guide cavities, the filter material within the guide cavities forming light ; curing the filter material; and applying a passivation layer over the device base that extends over the light guides.
22. The method of claim 21, further comprising applying a shield layer to the outer surface of the device base prior to applying the passivation layer, and forming res through the shield layer between the peripheral crosstalk shields, wherein the passivation layer extends directly along the shield layer and across the apertures. 1I11 ' -Control System i 110 104 I E I ' 102 I System Fluidic I4/ I ller COMFOI System 1 06 I i : I - F|G
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361914275P | 2013-12-10 | 2013-12-10 | |
US61/914,275 | 2013-12-10 | ||
NZ720871A NZ720871A (en) | 2013-12-10 | 2014-12-09 | Biosensors for biological or chemical analysis and methods of manufacturing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ759805A NZ759805A (en) | 2021-08-27 |
NZ759805B2 true NZ759805B2 (en) | 2021-11-30 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11719637B2 (en) | Biosensors for biological or chemical analysis and methods of manufacturing the same | |
US11080248B2 (en) | Biosensors for biological or chemical analysis and systems and methods for same | |
AU2018258080B2 (en) | Sensors having integrated protection circuitry | |
US20230027409A1 (en) | Methods and systems for real time extraction of crosstalk in illumination emitted from reaction sites | |
NZ759805B2 (en) | Biosensors For Biological Or Chemical Analysis And Methods Of Manufacturing The Same | |
US20220414839A1 (en) | Methods and systems to correct crosstalk in illumination emitted from reaction sites | |
US20230076689A1 (en) | Flow cell image sensor arrangement with reduced crosstalk |